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Abstract 
Characterizing the Interaction of the ATP Binding Cassette Transporters  
(G subfamily) with the Intracellular Protein Lipid Environment 
    Sonia Gulati 
 Cholesterol is an essential molecule that mediates a myriad of critical 
cellular processes, such as signal transduction in eukaryotes, membrane fluidity, 
and steroidogenesis.  As such it is not surprising that cholesterol homeostasis is 
tightly regulated, striking a precise balance between endogenous synthesis and 
regulated uptake/efflux to and from extracellular acceptors.  In mammalian cells, 
sterol efflux is a key component of the homeostatic equation and is mediated by 
members of the ATP binding cassette (ABC) transporter superfamily.  
ATP-binding cassette (ABC) transporters represent a group of 
evolutionarily highly conserved cellular transmembrane proteins that mediate the 
ATP-dependent translocation of substrates across membranes.  Members of this 
superfamily, ABCA1 and ABCG1, are key components of the reverse cholesterol 
transport pathway. ABCG1 acts in concert with ABCA1 to maximize the removal 
of excess cholesterol from cells by promoting cholesterol efflux onto mature and 
nascent HDL particles, respectively. To date, mammalian ABC transporters are 
exclusively associated with efflux of cholesterol. In Saccharomyces cerevisiae, 
we have demonstrated that the opposite (i.e inward) transport of sterol in yeast is 
also dependent on two ABC transporters (Aus1p and Pdr11p). This prompts the 
question what dictates directionality of sterol transport by ABC transporters. The 
main focus of this study is to define the parameters that result in sterol movement 
across membranes. The comparison between these contrasting states (outward 
v. inward transport of the same substrate) will allow us to dissect whether sterol 
transport across the plasma membrane is defined by the molecule (i.e. the ABC 
transporter) or by microenvironment (i.e. the status of other proteins and lipids) in 
which it resides. 
We have developed the model eukaryote Saccharomyces cerevisiae as a 
tool to understand the mechanisms that influence ABC-transporter mediated 
   
movement of sterols.  Specifically, we expressed murine ABCG1 (mABCG1) in 
yeast and assessed how changes in the intracellular sterol environment affect 
movement of sterols by this transporter. We found that expression of mABCG1 is 
able to vary (both increase and decrease) the concentration of exogenous sterols 
in the cell in response to intracellular sterol changes. We also found that yeast 
members of the ABCG subfamily, Aus1p and Pdr11p are able to promote either 
influx of cholesterol or efflux of a cholesterol derivative depending on the sterol 
context of the cell. This is the first example of an ABC transporter mediating bi-
directional transport. These data suggest that direction of transport is not a static 
property of the transporter but rather can adapt in response to changes in the 
intracellular microenvironment.  
In addition to sterols we also found that proteins in the microenvironment 
may also influence direction of transport. Specifically, we found that the yeast 
sterol esterifying enzyme Are2p, physically interacts with the ABC transporters 
Aus1p and Pdr11p.  Furthermore, all three proteins were found to co-localize to 
detergent resistant membrane microdomains. Deletion of either ABC transporter 
resulted in Are2p re-localization from DRMs to a detergent soluble fraction as 
well as a significant decrease in the percent of sterol esterified.  This 
phenomenon is evolutionarily conserved in the murine lung where ABCG1 and 
ACAT1 were observed to co-localize with flotillin-1, a marker of DRMs.  We 
propose that co-localization and complex formation of sterol esterification 
enzymes and ABC transporters in DRMs reflects a novel mechanism that directs 
membrane sterols to the esterification reaction.  
The studies presented in this thesis provide evidence that direction of 
transport is not a static inherent property of the transporter, but rather that it is 
mutable and influenced by surrounding sterols and proteins. The data provided 
here offers further insight as to how ABC transporters move cholesterol from the 
membrane and therefore may provide a platform for innovative strategies to 
combat atherosclerosis.
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Chapter 1: An Overview of Sterol Homeostasis in Model Systems 
 
 
    Preface 
The origins of cholesterol research can be traced back to pre-revolutionary 
France where cholesterol was initially discovered in human gallstones and later 
purified in 1815 (1). Today, cholesterol has become a household word and easily 
one of the most studied endogenously synthesized molecules (1). The 
fascination with cholesterol stems from the fact that it is essential for life but if 
deregulated, instigates death.  Dysregulation of cholesterol metabolism 
contributes to the pathogenesis of such potentially fatal diseases as 
atherosclerosis, diabetes, and Alzheimerʼs (1). Over the last two centuries great 
strides have been made in elucidating the biosynthesis, metabolism, and 
regulation of cholesterol (2). However, by no means is cholesterol research 
complete or depreciating, as many facets of cholesterol metabolism have yet to 
be illuminated. In this thesis I will expound on one of these facets by 
characterizing the energy dependent movement of cholesterol across the plasma 
membrane and its subsequent intracellular distribution.  
Cholesterol Structure and Significance 
Cholesterol is an essential lipid present in the membranes of most 
eukaryotes. It is a seventeen-carbon polycyclic compound consisting of a four 
ring steroid structure with a hydroxyl group at C3 and a double bond at C5 and 
C6 (2).  In the membrane bilayer, cholesterol is intercalated between the fatty 
acid chains of neighboring phospholipids, with its polar hydroxyl group adjacent 
to the phospholipid head groups (3). Cholesterol promotes a liquid ordered phase 
of the bilayer by modulating fluidity based on the degree of saturation of 
neighboring fatty acid chains (3). In addition to regulating membrane fluidity, 
cholesterol serves as an essential precursor for physiologically important 





Cholesterol in Membranes 
Cholesterol is heterogeneously disseminated across the membranes of 
the secretory system (4).  In human fibroblasts approximately 85% of unesterified 
cholesterol is found in the plasma membrane, 10% in the endocytic pathway, and 
0.5% in the endoplasmic reticulum (ER) (5).   Within the plasma membrane 
cholesterol segregates into regions of membranes with strongly hydrated large 
head groups, like those found in sphingolipids, to form liquid-ordered membrane 
microdomains or lipid rafts (3). Lipid rafts are defined as small (10–200 nm), 
heterogeneous, highly dynamic, sterol- and sphingolipid-enriched domains that 
can sometimes be stabilized to form larger platforms through protein-protein and 
protein-lipid interactions (6). They represent as much as 30% of the plasma 
membrane and contain twice as much cholesterol and one and a half times the 
sphingolipids as the surrounding bilayer (7). The coalescence of these lipids into 
membrane micro-domains, likely functions to enhance the physical structure of 
the membrane as well as generate foci that integrate pathways such as lipid 
influx and efflux, protein trafficking, signal transduction, and even viral entry (8). 
The concept of lipid rafts presented in 1997, transformed the field of 
membrane biology, in that it altered the perception that lipids in the bilayer were 
just structural passive solvents (9). Experimentally however, the study of lipid 
rafts stagnated due to the inability to define the specific components (lipids and 
proteins) of rafts or assess with certainty their existence. A major impediment to 
studying lipid rafts is that they have poorly defined morphology (unlike lipid bound 
organelles or caveolae) and are too small to resolve via conventional microscopy 
(10). As such the burden of proof for their existence has relied on the biochemical 
attributes of these complexes (9). The first working biochemical definition of lipid 
rafts was suggested by Brown and Rose who reported that cholesterol, 
sphingolipids, and GPI anchored proteins are insoluble in Triton X-100 at 4°C 
and floated to a characteristic density following equilibrium density gradient 
centrifugation (11). Detergent insolubility quickly became the governing principle 
in determining lipid and protein raft affinity. Although biophysical studies of model 
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membranes demonstrated that lipids in the liquid-ordered phase are resistant to 
detergent solubilization, they also showed that treatment of membranes with 
detergents can create artificial membrane domains (12).  This latter point coupled 
with the observation that raft components may vary based on the concentration 
and type of detergent utilized became a point of contention in the lipid raft field. 
Detergent screens have shown that less efficient detergents such as the Brij 
series, Lubrol, and Tween-20 do produce a distinct, less temperature sensitive, 
and diminished cholesterol dependent subpopulation of the membrane (13-15). 
Despite its imperfections, detergent resistance remains the only biochemical 
means of isolating lipid rafts and has contributed to many breakthroughs in the 
field (6). Today, data provided by detergent resistance is being corroborated by 
the findings of such innovative techniques as stimulated emission depletion far-
field fluorescence and fluorescence correlation spectroscopy that have been able 
to detect lipid rafts under physiological conditions (16,17). 
Cholesterol Synthesis and Trafficking 
An estimated 70% of total body cholesterol is derived from de novo 
synthesis. Cholesterol biosynthesis occurs in all mammalian cells, however this 
capacity is greatest in liver, adrenal cortex, and reproductive tissues (18). The 
synthesis of cholesterol is a multi-step process involving nearly 30 enzymes. The 
rate-limiting step of this pathway HMG-CoA reductase catalyses the formation of 
mevalonate and is also the target of cholesterol lowering pharmaceuticals such 
as the statins (2). Mevalonate is then subjected to a series of phosphorylations 
and a decarboxylation reaction to produce isopentenyl pyrophosphate, an 
activated isoprenoid molecule. IPP is subsequently converted to squalene, which 
undergoes cyclization to produce lanosterol. Ultimately, lanosterol is converted to 
cholesterol through 19 additional reactions (2). Cholesterol metabolism is 
transcriptionally regulated by sterol regulatory element binding proteins 
(SREBPs), a group of master regulators that control the feedback regulation of 
synthesis and uptake of many lipids, at many steps (19). Cleavage of the 
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membrane associated SREBP protein by two proteases in the Golgi complex 
releases a soluble amino-terminal transcription factor domain. The domain is 
then translocated to the nucleus where it activates the transcription of target 
genes (20). Numerous accessory proteins (SREBP cleavage activating protein 
SCAP and INSIGs 1 or 2) and proteases (S1p and S2p) mediate the sensing of 
membrane composition, fluidity, and the subsequent translocation and activation 
of the transcription factor (19). This process is repressed when cellular sterol 
concentrations peak; recent studies elegantly describe the manner in which ER 
cholesterol concentrations greater that 0.5 mol% are sufficient to block ER exit of 
SREBP and the cholesterol sensor, SCAP (21). Further fine-tuning of cholesterol 
biosynthesis via post-translational regulation of HMG-CoA reductase is achieved 
through INSIG1 dependent proteasomal degradation, which also responds to 
cholesterol levels in the ER (22,23). 
Humans also obtain one-third of their total body cholesterol via their diet 
(24). Dietary cholesterol along with triglycerides are absorbed by enterocytes of 
the small intestine and packaged into chylomicrons (24). These lipoproteins enter 
the circulation where they adhere to the inner surface of capillaries of skeletal 
muscle and adipose tissue.  At these tissues, triglyceride distribution occurs first 
via hydrolysis by lipoprotein lipase.  The residual components (including 
cholesterol) of the chylomicron re-enter circulation and are subsequently taken 
up the by the liver (24).  Like the intestines, the liver generates cholesterol 
transport carriers called very low-density lipoproteins (VLDL), which resemble 
chylomicrons both structurally and functionally.  In circulation, VLDL undergoes a 
successive depletion of triglycerides transforming it into a cholesteryl ester-laden 
remnant particle, known as low-density lipoprotein (LDL). Cholesterol delivery to 
peripheral tissues is facilitated by the uptake of LDL via the LDL receptor (25). 
Excess cholesterol in extrahepatic tissues can be transported back to the liver by 
high-density lipoprotein (HDL) via the reverse cholesterol transport pathway (26).  
At the liver, cholesterol is secreted into bile (either as cholesterol or after it has 
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been metabolized to bile acids) that enters the small intestine, where it is either 
reabsorbed (enterohepatic cycle) or excreted into feces (27).  
Sterol Homeostasis 
A myriad of biological processes work in concert to impart cholesterol 
homeostasis, including transcriptional regulation of the biosynthetic pathways, 
translocation of the products between and within membranes, efflux to 
extracellular acceptors, and catabolism to inert but recoverable storage forms 
such as steryl esters (28). The following is an overview of some of the key 
cholesterol homeostatic events with a particular emphasis placed on those 
aspects (esterification and efflux) that I will explore in this thesis. 
 
Esterification of sterols 
The esterification of sterols by the acyl-coenzyme A:cholesterol acyl-
transferases (ACATs) is a fundamental reaction in eukaryotic cells that is 
conserved throughout evolution (29).  Cholesteryl esters, the products of this 
reaction can be packaged into lipoproteins or stored in cytosolic lipid droplets as 
a means to protect the cell from cholesterol toxicity (29). In mammalian cells, the 
ACAT gene family is tripartite, consisting of ACAT1, ACAT2 and DGAT1 (the 
latter enzyme esterifies diacylglycerol) (30-32).  
ACAT1 Gene and Protein Structure 
In humans, Soat1 (the gene encoding for ACAT1) is located on two 
different chromosomes, chromosome 1 and 7, with each chromosome containing 
a distinct promoter. Promoter P1 (located on chromosome 1) is contiguous with 
exons 1-16 and promoter P7 (located on chromosome 7) is contiguous with the 
optional long exon, Xa (29,33).  Of the known four human Soat1 splice variants, 
the 2.8-kb and 3.6kb mRNA contain a short 5ʼ untranslated region and constitute 
approximately 75% of the total Soat1 mRNAs that are produced from the P1 
promoter. These mRNAs are translated into a single 50 kDa protein band, which 
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is the major ACAT1 isoform observed in tissue (33). The 4.3-kb Soat1 mRNA 
consists of exon Xa and is produced from two different chromosomes by a novel 
RNA recombination event. This splice variant of human Acat1 can produce two 
isoforms, a 50 kDa protein and a minor 56 kDa  protein with different enzymatic 
activities (34). Zhao et al. have shown that the presence of exon Xa, impairs the 
production of the major isoform of the ACAT1 protein by promoting its mRNA 
decay.  This phenomenon appears to be human specific as the murine Soat1 
gene does not contain the optional exon Xa (34). 
  Although the exact structure of ACAT1 is unknown, data by Guo et al. 
suggests that it contains nine transmembrane domains, with the amino terminus 
located in the cytosol and the carboxyl terminus embedded in the ER lumen (34). 
ACAT1 is comprised of two putative N-terminal leucine zipper motifs located at 
aa 47−61 and aa 80−94. Deletion of the former putative leucine zipper results in 
a functional dimeric form with increased catalytic activity (30). It is unclear 
whether the latter putative leucine zipper motif participates in the 
homotetramerization of ACAT1 or if it mediates the interaction with other 
proteins. Transmembrane domains 7 and 8 contain coiled coil domains that have 
two distinct functions.  One side of the domain promotes subunit interaction 
whereas the other side is involved in substrate binding and/or enzymatic 
catalysis (35).  Sequences in transmembrane domains 1,2, and 4-6 are highly 
conserved amongst the ACATs but not the DGAT enzymes, suggesting that 
these regions may play a role in cholesterol binding (36).  Conversely, the motif 
FYXDWWN (amino acids 403-409 of human ACAT1) and MKXXSF (amino acids 
265–270 of human ACAT1) are highly conserved amongst all family members, 
the former maybe involved in fatty acyl-CoA binding and the latter, specifically the 
serine residue is required for ACAT activity (37). In addition, all members of this 
enzyme family have a potential tyrosine phosphorylation motif and at least one N-




ACAT1 cellular and tissue distribution 
ACAT1 is a homotetrameric enzyme primarily found in the ER (39). 
However, this localization is not static, as it changes with varying cell condition. In 
nonadherent mouse macrophages, 10–15% of ACAT1 immunoreactivity was 
localized to the cell surface (40). In cholesterol-loaded human macrophages, 20–
40% of ACAT1 immunoreactivity was found in small vesicles, observed near the 
trans-Golgi network and the endocytosis recycling compartment (41). 
  ACAT1 mRNA is ubiquitously expressed in mammalian tissues with the 
highest expression levels occurring in the adrenal glands, macrophages, and 
sebaceous glands, all of which store cholesteryl esters in cytoplasmic droplet 
(42). Human ACAT1 protein is also found in hepatocytes and Kupffer cells of the 
liver, neurons, and atherosclerotic lesions (41). Immunodepletion experiments in 
human tissues have suggested that human ACAT1 accounts for nearly all of the 
ACAT activity in the liver, adrenal gland, macrophages, and kidney, but only 
about 20% of the activity in small intestine (43).  Murine distribution of ACAT1 is 
similar to that of the human enzyme, except that it is not the major ACAT isoform 
in the liver (38).  
Biological activity and regulation of ACAT1 
ACAT1 catalyzes the formation of an ester bond between the carboxylate 
group of a fatty acid and the hydroxyl group of cholesterol.  In extrahepatic cells, 
cholesteryl esters generated by ACAT1 are shuttled out of the ER and into 
cytoplasmic lipid droplets.  In hepatocytes, cholesteryl esters are recruited to the 
ER lumen where they are packaged into the neutral core of a VLDL particle (38).  
ACAT1 activity accounts for more than 80% of the total ACAT enzyme activity in 
vitro. ACAT1 is primarily allosterically regulated by its substrates, cholesterol and 
oxysterols (38).  In cholesterol-loaded cells, esterification increased without a 
concomitant change in expression level of ACAT1 mRNA or protein (44).  
Allosteric regulation allows ACAT1 to respond rapidly to changes in intracellular 
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cholesterol levels, suggesting that cholesteryl esterification may be a first-line 
defense in preventing cholesterol toxicity (29).   
 Although ACAT1 is mainly regulated allosterically, evidence for 
transcriptional regulation began to emerge from a study examining how 
glucocorticoids increase the incidence of atherosclerosis (45).  This study found 
that dexamethasone treatment resulted in a 60% increase in ACAT1 activity as 
well as an increase in hSoat1 mRNA (45). Consistent with these results it was 
later found that the hSoat1 P1 promoter possesses a glucocorticoid response 
element (29). Other proatherogenic molecules such as the cytokine, interferon-γ  
and the hormone Urotensin-II have also been found to upregulate hSoat1 
expression in macrophages.  In addition, atheroprotective agents such as 
adiponectin and adipocytokine downregulate hSoat1 expression (29). In the liver, 
Soat1 mRNA expression increased 2-3 fold when mice or rabbits were fed a diet 
rich in fat and cholesterol (46).  The modulation of hSoat1 mRNA by atherogenic 
molecules and presence of the ACAT1 protein in atherosclerotic lesions suggests 
that it may conduce the initiation of athersclerosis (38). 
In vivo function of ACAT1 
 ACAT1 null mice were generated in order to further elucidate the 
physiological role of ACAT1 and its contribution to the development of 
atherosclerosis. ACAT1-deficient (ACAT1−/−) mice are healthy with normal serum 
cholesterol, intestinal cholesterol absorption, and hepatic ACAT activity (40). The 
most profound effects of ACAT1 deficiency was observed in the adrenal gland, 
testis, and ovary, where ACAT activity was reduced by more than 95% (38).  
Furthermore, cholesteryl esters were nearly undetectable in the adrenal cortex, 
ovaries (47), and cultured peritoneal macrophages (38).  Despite the loss of 
ACAT activity and depletion of cholesteryl esters in the adrenal gland, 
corticosterone synthesis was normal, suggesting a functional redundancy in 
pathways providing cholesterol for steroidogenesis(38).  In addition, cholesteryl 
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esters were depleted in the meibomian glands resulting in dry eye and a 
narrowing of the eye opening by age 3-4 weeks, a physical hallmark of ACAT1 
deficient mice (47). 
 To test the hypothesis that ACAT1 activity in macrophages promotes the 
pathogenesis of atherosclerosis, ACAT1−/−mice were crossed with two strains of 
mice that are susceptible to atherosclerosis: low density lipoprotein receptor-
deficient (LDLR−/−) mice and apoE-deficient (apoE−/−) mice. ACAT1 deficiency in 
both backgrounds resulted in a significant increase in the deposition of free 
cholesterol in the skin and in the brain (47). However, the effect of ACAT1 
deficiency on the development of atherosclerosis was inconclusive. A study 
performed by Chiwata et al. found that ACAT1 deficiency was associated with an 
estimated 50% reduction in aortic root lesions in LDLR−/− mice and did not 
decrease serum cholesterol levels (48).  Conversely, Fazio et al. showed that 
LDLR−/− mice reconstituted with ACAT1−/− macrophages had increased 
atherosclerotic lesions that contained more free cholesterol and fewer 
macrophages than control lesions (49). The differences in results may in part be 
due to different strain background and varying methodology.  However, further 




ACAT2 gene and protein structure 
 The retention of normal hepatic ACAT activity in ACAT1−/− mice and the 
presence of two sterol esterifying ACAT-related enzymes in yeast, suggested 
that the esterification reaction in higher eukaryotes may also be catalyzed by 
multiple enzymes. In 1998, three laboratories cloned a gene encoding a second 
mammalian ACAT (31,50,51). The human ACAT2 gene, SOAT2, encodes for a 
2.2 kb mRNA and produces a 60 kDA protein, which is 43% identical to ACAT1 
(29).  In addition to this major isoform, Yao et al have found two human ACAT2 
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mRNA splice variants, ACAT2b and ACAT2c. Comparable amounts of the 
alternatively spliced ACAT2 mRNA variants and their corresponding proteins 
were detected in human liver and intestine cells (52). However, these 
isoenzymes exhibited a 25%-35% reduction in enzymatic activity as compared to 
the major isoform, which may attributed to the absence of a phosphorylation site 
SLLD, found in the major isoform (9).  
ACAT2 has a high degree of sequence similarity with ACAT1 near the 
carboxy terminus and also possesses multiple transmembrane domains (50). 
However, the actual number of transmembrane domains remains controversial.  
Both ACAT enzymes share a number of motifs including, the MKXXSF 
consensus sequence, a potential tyrosine phosphorylation site, a leucine zipper 
motif, and two potential N-linked glycosylation sites (38).  The consensus 
sequence (specifically the serine residue) is essential for ACAT activity and is 
located in the ER lumen for ACAT2 and in the cytoplasm for ACAT1. This 
suggests that the active sites of these enzymes reside on opposite sides of the 
ER membrane (29). 
ACAT2 cellular and tissue distribution 
ACAT2 is an integral membrane ER protein (50).  It is predominantly 
expressed in the enterocytes of the small intestine and the fetal liver (51).  In 
addition, ACAT2 is also expressed in the human adult liver, although the extent 
of its expression is contentious. Parini et al. showed that both ACAT1 and ACAT2 
are present in hepatocytes and in 75% of the liver samples examined, ACAT2 
was responsible for more than 50% of the total ACAT activity (53).  Conversely, 
Smith et al., demonstrated that on average ACAT1 mRNA was nine-fold more 
abundant than ACAT2 mRNA in hepatocytes. They also found that ACAT1 
mRNA levels were far more constant, whereas ACAT2 mRNA levels fluctuated 
(54). Additionally, elevated levels of ACAT2 mRNA have been observed in a 
subpopulation of patients with hepatocellular carcinoma. In contrast to humans, it 
is established that ACAT2 is the major isoform in murine liver (29). 
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Biological activity and regulation of ACAT2 
ACAT2, like ACAT1, catalyzes the esterification of cholesterol with fatty 
acids.  Specifically, in the small intestine, ACAT2 esterifies the cholesterol 
absorbed by the body so that it may be more efficiently packaged into 
apolipoprotein B-containing lipoproteins (50). Immunodepletion experiments have 
shown that ACAT2 accounts for 80-90% of activity in the adult small intestine and 
fetal liver, whereas it only accounts for 10% of ACAT activity in the human adult 
liver (38).  
ACAT2 is allosterically regulated by cholesterol and transcriptionally by 
Cdx2 (caudal type homeobox transcription factor 2) and HNF1α (hepatocyte 
nuclear factor 1alpha). Both Cdx2 and HNF1α work synergistically to promote the 
expression of hSOAT2 (29). HNF1α is expressed in a myriad of tissues including 
hepatocytes, kidney, and the intestinal epithelium. In contrast, Cdx2 is a largely 
an intestine specific transcription factor. Interestingly, in normal adult human liver, 
Cdx2 expression is virtually undetectable and consequently ACAT2 expression 
levels are very low as well (29). However, in certain models of hepatocellular 
carcinoma, Cdx2 and subsequently ACAT2 expression is significantly elevated. 
This observation may explain the conflicting data regarding ACAT2 expression 
and activity in the liver (55). 
 
In vivo function of ACAT2 
Further insight into the specific biological role of ACAT2 has been 
garnered from knockout models in mice.  ACAT2−/− mice have nearly 
undetectable ACAT activity and lack cholesteryl esters in the liver and small 
intestine (56). ACAT2−/− mice exhibit a decreased ability to absorb dietary 
cholesterol, a resistance to diet induced hypercholesterolemia, and gallstone 
formation (56).  These data suggests that murine ACAT2 plays a key role in 
regulating the response to dietary cholesterol (38). 
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To ascertain the contribution of ACAT2 to the development of 
atherosclerosis, ACAT2−/− mice were crossed with an atherosclerosis-susceptible 
strain, ApoE–/–. These mice exhibited high levels of total plasma lipids and an 
increase in apolipoprotein-B particles that were rich in trigylcerides and void of 
any cholesteryl esters (57). Despite elevated levels of total plasma and apo-B 
particles, the ACAT2 deficient mice in the ApoE–/– background were almost 
completely protected from atherosclerosis (57). Willner et al suggested that the 
altered composition of the apoB particle in the double knockout mice made it less 
atherogenic. These data connote that cholesteryl esters catalyzed by ACAT2 
contribute to the onset of atherosclerosis in mice and therefore may be a salient 
drug target in humans (57). 
 
ACAT inhibitors 
The discovery that the ACAT reaction contributes to the formation of both 
the macrophage "foam cell" and the atherogenic apolipoprotein B–containing 
lipoproteins, suggested that inhibiting this reaction maybe key in preventing or 
treating atherosclerosis (58). Several animal studies involving nonselective ACAT 
inhibitors showed a promising reduction of atherosclerotic plaques. Unfortunately, 
human trials proved to be disappointing, likely because generalized ACAT 
inhibition leads to an increase in free cholesterol levels, apoptosis, and 
destabilization of ATP binding cassette A1 (32). However, the finding that ACAT2 
deficiency in a pro-atherogenic mouse model was athero-protective, suggested 
that ACAT2 specific inhibition may prove more fruitful (57). In fact, Bell et al. 
demonstrated that liver ACAT2 specific inhibition in atherosclerosis prone mice 
were resistant to diet-induced hypercholesterolemia and had fewer aortic 
atherosclerotic lesions (59).  However, unlike in mice, ACAT2 is not the major 
isoform in human liver and therefore this may prove to be a confounding factor 
when translating these results to humans (60). 
 Cholesterol homeostasis is achieved by a myriad of pathways working 
contemporaneously. The esterification of sterols by the ACATs is one 
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indispensible component of homoestasis. The efflux of cholesterol by ATP 
binding cassette (ABC) transporters represents another fundamental arm of this 
system (4). Together the ACATs and ABC transporters help maintain optimal 
intracellular sterol levels for normal cell function (18).  
 
Cholesterol Efflux by ABC Transporters 
ABC transporters 
ATP-binding cassette transporters harness the energy of ATP binding 
and/or hydrolysis to transport a diverse set of hydrophobic molecules across 
membranes. ABC transporters represent one of the largest transporter gene 
families that are evolutionarily conserved (61). These transporters have a 
canonical architecture that consists of two transmembrane domains and two 
nucleotide binding domains. These domains can either be found in tandem in a 
single molecule or allocated to separate proteins, which must dimerize to form a 
functional transporter. The transmembrane domains are comprised of alpha 
helices that are embedded in the membrane whereas the nucleotide binding 
domains extrude into the cytoplasm (62). The nucleotide binding domain contains 
a set of highly conserved motifs such as the Walker A, Walker B, and the ABC 
signature motif, which is the hallmark of this protein superfamily (63). Conversely, 
the transmembrane domains exhibit a significant amount of diversity both in 
sequence and architecture, reflecting the heterogeneity of this superfamilyʼs 
substrates (63).  Human ABC transporters are classified into seven families (six 
of which are also found in the Saccharomyces cerevisiae genome), based on 
similarity in gene structure (half versus full transporters), order of the domains, 
and on sequence similarity in the nucleotide binding and transmembrane 
domains (63). ABC transporters mediate the transport of various amphiphilic 
ligands including, sterols, phospholipids, and xenobiotics. As such, they 
participate in diverse biological processes such as cell signaling, drug resistance, 




Cholesterol and lipid efflux by ABC transporters 
Members of this superfamily were first implicated in lipid transport when 
the classical drug transporters, MDR1 and MDR3 were shown to mediate 
phospholipid efflux (64). This novel concept that would later define a subset of 
ABC transporters was substantiated when it was discovered that ABCA1 is a key 
regulator of HDL metabolism (65). In 1998, several groups discovered that 
mutations in ABCA1 are the underlying defect in Tangier disease, a disease 
characterized by the virtual absence of HDL cholesterol (66-68). Functional 
studies showed that ABCA1 promotes the efflux of cholesterol and phospholipids 
to apolipoprotein A1, a nascent HDL particle (69). As a result, ABCA1 is a major 
determinant of plasma HDL levels. To date, 20 ABC transporters have been 
shown to mediate lipid and/or cholesterol flux across membranes (Table 1) (70).  
ABCG Subfamily of ABC Transporters 
 The mammalian ABCG subfamily consists of 6 transporters, a majority of 
which, play a pivotal role in sterol transport and metabolism. Mammalian 
members in this subfamily are half-transporters comprised of a single nucleotide 
binding domain and a single transmembrane domain (71). The hallmark of this 
particular subfamily is its characteristic topology, in which the nucleotide binding 
domain is located N-terminal to the transmembrane domain. These transporters 
are orthologs of the Drosophila gene White, which forms obligate heterodimers 
with Scarlet or Brown in order to mediate the uptake of eye pigment precursors 
(33). Similarly, mammalian members of this subfamily must also form 
homodimers or obligate heterodimers in order to become functionally active (33).  
 Below is an overview of the physiologic function and relevance of the five 
mammalian members (ABCG1, G2, G4, G5, and G8) of the ABCG subfamily. A 
particular emphasis is placed on ABCG1, as its specific biological role in 






ABCG2 and ABCG3 
 ABCG2 is a homodimer that localizes to the plasma membrane of 
epithelial cells in various tissues including the placenta, kidney, and intestine 
(72,73). In these tissues ABCG2 is thought to play a role in regulating the efflux, 
absorption and circulation of xenobiotics. ABCG2 is highly expressed in tumor 
cells where it mediates multi-drug resistance to various chemotherapeutic agents 
(72). Unlike other mammalian members of this subfamily, a lipid substrate for 
ABCG2 has not been identified. In order to better understand the physiological 
role of ABCG2, abcg2-/- mice were created (74,75). To date, these mice do not 
display a distinctive phenotype. However, they do have increased levels of a 
heme precursor, protoporphyrin IX in plasma and erythrocytes (75).  
ABCG3 is 54% identical to ABCG2 and was identified as a result of a 
computer search of EST databases. ABCG3 is highly expressed in the thymus 
and spleen, however its function is unknown  (76). 
 
ABCG4 
 ABCG4 and ABCG1 are 82% identical and exhibit overlapping functions. 
Overexpression of either protein in HEK293 cells promotes the efflux of 
cholesterol to mature HDL particles (69,77). In order to become functionally 
active  ABCG1 and ABCG4 must either homodimerize or heterodimerize with 
each other.  Despite their high homology and shared function, ABCG1 and G4 
exhibit a disparate tissue distribution and transcriptional regulation. ABCG4 
unlike ABCG1 is not regulated by the liver X receptor (LXR) and possesses a 
more restricted expression profile (78). ABCG4 is predominantly expressed in 
various cell types of the central nervous system (78). However, abcg4-/- mice do 
not display any overt neurological phenotypes (33). In contrast, the brains of 
Abcg1−/−Abcg4−/− mice exhibited a significant increase in both the cholesterol 
metabolite 27-hydroxycholesterol and in the levels of several intermediates of the 
cholesterol biosynthetic pathway (79). Additionally, astrocytes from these mice 
showed a signficiant decrease in the efflux of cholesterol and desmosterol to 
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HDL. These data suggest that ABCG1 and ABCG4 may work synergistically in 
astrocytes to promote the efflux of desmosterol and cholesterol to HDL like 
particles (79). 
 The cellular localization for both ABCG1 and ABCG4 remains elusive. 
Localization studies have produced discordant results, with one study proposing 
that both proteins co-localize to the plasma membrane and another study 
showing that they localize to endosomes (71). Additional studies are needed to 
more precisely define the subcellular localization and molecular role of ABCG4.  
 
ABCG5 and ABCG8 
Two tandemly aligned genes, ABCG5 and ABCG8, encode for proteins 
that act as obligate heterodimers to promote sterol efflux into bile and the 
intestinal lumen. ABCG5 and ABCG8 are coordinately expressed and induced 
following activation of LXR (71).  Both transporters localize to the apical 
membranes of intestinal enterocytes and the canalicular membranes of 
hepatocytes. Deletion of either half transporter results in the retention of the other 
in the ER as a consequence of impaired translocation to the plasma membrane 
(80). Functional and structural studies demonstrated that the nucleotide binding 
domains of ABCG5 and ABCG8 are not functionally equivalent (80). These 
studies found that Walker A and Walker B motif from ABCG5 and the signature 
motif of ABCG8 were required for ATP binding and hydrolysis (80). Initial 
characterization of these transporters by Hobbs et al., demonstrated that 
mutations in ABCG5 or ABCG8 were the underlying cause for β-sitosterolemia, a 
rare autosomal recessive disorder.β-sitosterolemia is primarily characterized by a 
significant increase in plasma and tissue plant sterols. Patients may also present 
with other lipid abnormalities such as the deposition of sterols in the skin 
(xanthomas) and coronary arteries (81).  
Analysis of Abcg5−/−Abcg8−/− mice confirmed the role of these transporters 
in β-sitosterolemia, as these mice exhibited a 3-fold increase in dietary plant 
sterol fractional absorption, a 30% increase in plasma sitosterol levels, and a 
  
17 
reduction in biliary cholesterol levels (81). In addition, substrate specificity was 
gleaned from these studies as the double knockout mice exhibited low levels of 
biliary cholesterol only, not bile acids or phospholipids (82). By controlling sterol 
intestinal absorption and hepatic excretion, ABCG5 and ABCG8 effectively limit 
circulating sterols in plasma, suggesting that modulation of the activity of these 
transporters might be used as a novel therapeutic intervention in the treatment of 
hypercholesterolemias. Indeed, Ldlr−/− mice overexpressing both ABCG5 and 
ABCG8 showed a marked decrease in circulating cholesterol and reduced 
atherosclerotic lesions, compared to Ldlr−/− controls (83). 
 
ABCG1  
ABCG1 Gene and Protein Structure 
In 1997, human ABCG1 cDNA was identified and found to encode for a 74 
kDa protein (678 amino acids) that exhibited 33% identity with the Drospophila 
white gene (84). ABCG1 is comprised of 23 exons and is found on chromosome 
21 as well as on the corresponding locus of murine chromosome 17 (84).  Seven 
ABCG1 splice variants have been identified and differ only at the amino terminus. 
In mice, ABCG1678 is the predominant splice variant, however for humans the 
major transcript has yet to be established (85). Engel et al., investigated the 
expression patterns and functionality of a shorter splice variant ACBG1666, an 
isoform in which 12 amino acids in the cytoplasmic domain (found between the 
transmembrane region and the ATP cassette) have been spliced (85,86). They 
demonstrated that ABCG1666 localizes to the plasma membrane where it is able 
to promote cholesterol efflux and form a homodimer (85). Furthermore, they 
found that ABCG1666 expression was two fold higher than ABCG1678 in human 
monocyte-derived macrophages and liver (85). Gelissen et al., further 
corroborated these findings and in addition found that ABCG1678 had a shorter 
half life than ABCG1666 under basal conditions (86). 
Multiple response elements and promoters at various positions have been 
identified for ABCG1. ABCG1 contains a TATA promoter and two functional LXR 
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response elements upstream of exon 8. Conversely, a TATA-less promoter is 
found upstream of exons 1, 4, 5, and 6. In addition, a putative PPAR/RXR binding 
motif (upstream of exon 1), a putative sterol response element (upstream of exon 
5), and a two putative RXR binding motifs (upstream of exon 5) have also been 
identified (73).  
 
ABCG1 Tissue and Cellular Distribution 
The subcellular localization of ABCG1 remains controversial, as it seems 
to vary by cell type, culturing conditions, and detection techniques. Intracellular, 
perinuclear, and cell surface localization of ABCG1 have all been reported in a 
variety of cells including macrophages, baby hamster kidney cells, and mouse 
pancreatic beta cells (87-89). Further imbuing the controversy was conflicting 
data from Xie et al and Wang et al, regarding whether LXR activation induced 
ABCG1 relocation from intracellular compartments to the plasma membrane 
(90,91). To date there is no consensus regarding ABCG1ʼs intracellular 
localization.  It is clear that further studies are necessary to elucidate ABCG1ʼs 
intracellular trafficking and subsequent localization (33). 
Abcg1 is expressed in various murine and human tissues, however it is 
most highly expressed in the adrenal glands, lungs, heart, brain, and spleen (87). 
Abcg1 is also expressed in a myriad of cell types including macrophages, 
lymphocytes, epithelial cells, and neurons (87). 
 
Biological activity and regulation of ABCG 
Initial functional characterization of ABCG1 demonstrated that it mediates 
the efflux of intracellular cholesterol and choline-phospholipids to an HDL3 
particle (87).  Subsequently, overexpression studies have provided further insight 
as to the molecular role of ABCG1 by identifying protein partners, additional 
substrates, and novel acceptor molecules. Cross-linking experiments performed 
in both HEK293 cells and baby hamster kidney cells (BHK) illustrated that 
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ABCG1 functions as a homodimer. In addition, Western blot analysis detected 
several bands (120–150 kDa) after cross-linking suggesting that ABCG1 may 
interact with other unidentified proteins (88,92).  
ABCG1 acts as a functional dimer to promote cholesterol efflux to an array 
of acceptors including LDL, small phospholipid vesicles, and cyclodextrin. 
Kobayashi et al. revealed that ABCG1 is also able to mediate cholesterol and 
phospholipid efflux to BSA in a concentration-dependent manner, suggesting that 
secreted proteins may also function as an acceptor (92). Despite its promiscuity 
towards acceptor molecules, ABCG1 doesnʼt promote efflux to an Apo-A1 
particle, the predominant lipid acceptor of ABCA1 (93). This may in part be 
explained by the observation that ABCG1 requires cholesterol acceptors that 
contain phospholipids, whereas ABCA1 prefers phospholipid-free or phospholipid 
poor apolioproteins (93). Furthermore, unlike ABCA1, acceptor binding to the 
donor cell is not a requisite for ABCG1 mediated efflux. These data thereby 
posits that ABCG1 and ABCA1 work in distinct lipid efflux pathways (93).   
Overexpression of ABCG1 in BHK cells not only promoted efflux to an 
exogenous acceptor molecule, but also increased the flux of cholesterol to both a 
cholesterol oxidase accessible pool and an ACAT substrate pool (88). This 
observed increase was reduced in the presence of HDL suggesting that a 
fraction of the ABCG1-transported cholesterol not removed by HDL translocates 
from the cell surface to intracellular sites where it is esterified (88).  Based on 
these data, Vaughan and Oram propose that ABCG1 redistributes cholesterol to 
cell-surface domains where it becomes accessible for removal by HDL or is 
esterified by the ACATs (88).  
 In addition to promoting the transport of cholesterol and 
phosphotidylcholine, Sano et al showed that ABCG1 also mediates the efflux of  
sphingomyelin (92). In HEK293 cells expressing either ABCA1 or ABCG1, they 
found that the ratio of SM to PC effluxed by ABCG1 was eight times higher than 
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that transported by ABCA1. Therefore suggesting that ABCG1 preferentially 
secretes sphingomylein whereas ABCA1 prefers phosphtaydilycholine  (94).  
Since the homeostasis of cholesterol and sphingolipids is so tightly 
coordinated (28), it was not surprising that intracellular levels of sphingomyelin 
affected ABCG1 mediated cholesterol transport. Efflux of cholesterol and 
sphingomyelin by ABCG1 was reduced in LY-A cells, in which a mutation of the 
ceramide transfer protein CERT results in reduced intracellular sphingomyelin 
levels (94).  Corollary experiments with CHO-K1 cells overexpressing CERT 
displayed an increase in ABCG1 mediated efflux of cholesterol and 
sphingomyelin (54). The exact mechanism by which intracellular sphingomyelin 
levels affect ABCG1 mediated efflux remains elusive. However, Sano et al 
propose that ABCG1 may preferentially function in raft domains and therefore 
decreasing sphingomyelin levels results in a diminishing number of ABCG1 
containing raft domains (94).  Furthermore, it has been reported that HDL 
promoted the efflux of cholesterol from raft domains of human fibroblasts and 
macrophages (41).  
Although changes in intracellular sphingomyelin levels, have been shown 
to affect ABCG1 mediated transport, primary regulation of ABCG1 occurs at the 
transcriptional level.  Initial studies showed that ABCG1 mRNA levels were highly 
induced when macrophages were converted to lipid-loaded “foam” cells following 
incubation with modified low-density lipoproteins, specific oxysterols, or following 
the induction of the nuclear receptor liver-X-receptor (LXR) (95). Consistent with 
these observations, multiple functional LXR response elements (LXREs) have 
been identified in both the murine and human genes (95).  In addition, agonist 
activation of peroxisome proliferator-activated receptor, PPARγ results in 
increased expression of LXR and consequently LXR target genes that include 
ABCG1 and ABCA1 (71). Corroborating this data, Akiyama et al showed that 
hepatic expression of ABCG1 and ABCA1 was reduced in mice with a conditional 




In vivo function of ABCG1 
 In order to assess the precise physiological role of ABCG1, Abcg1−/−LacZ 
knock-in mice were generated. Surprisingly, unlike other LXR regulated ABC 
transporters (i.e ABCA1, ABCG5, and ABCG8), Abcg1−/− pups on a chow diet 
were healthy and did not exhibit any significant changes in weight, fertility, blood 
lipids, blood chemistry, or tissue pathology (43). However, when challenged with 
a high fat/high cholesterol diet, there was a significant accumulation of 
phospholipids, triglycerides, and cholesterol in the pulmonary macrophages, 
hepatocytes, and Kupffer cells (43).  In addition, the subpleural region of the 
lungs of Abcg1−/−  mice showed a significant increase in cholesterol clefts, 
lymphocytes, and the presence of classic macrophage foam cells. These 
phenotypes were rescued when hABCG1 was expressed in Abcg1−/−  mice. 
Interestingly, plasma lipids in Abcg1-/- remain unchanged even when on a high 
fat/high cholesterol diet (97). This suggests that unlike ABCA1, ABCG1 is not a 
major determinant of plasma HDL levels.  
 Although neutral lipid and cholesterol deposition occurred in both the lung 
and liver of Abcg1−/− pups fed a high fat/high cholesterol diet, the pulmonary 
lipidosis was most striking and continued to worsen with age (regardless of diet 
provided) (98).  The lungs of 8 month old Abcg1−/−  chow fed mice exhibited 
significant deposition of free and esterified cholesterol in alveolar macrophages, 
increased surfactant levels, and enlarged pneumocyte type 2 cells containing 
abnormal lamellar bodies. Furthermore, this lipidosis was accelerated when 
Abcg1−/− mice were fed a high-fat, high-cholesterol diet, suggesting that dietary 
lipids contribute to the sterol imbalance in the lungs (98). In addition, Abcg1−/ 
macrophages accumulated cholesteryl ester droplets when incubated with 
surfactant. Baldan et al., suggested that such a phenotype may be attributed to 
the continual cellular uptake of cholesterol-containing surfactant coupled with a 
defect in ABCG1-dependent sterol efflux (despite increased expression of 
ABCA1) (98).  
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 The accumulation of cholesteryl ester droplets in pulmonary Abcg1−/− 
macrophages, coupled with the pivotal role that ABCG1 plays in reverse 
cholesterol transport in vitro, suggests that a loss of ABCG1 may contribute to 
the onset and progression of atherosclerosis. In order to evaluate the role of 
ABCG1 in atherosclerosis, three laboratories independently performed bone-
marrow-transplant studies using donor cells from Abcg1−/− or wild-type mice and 
recipient hyperlipidemic Ldlr−/− mice (98-100). Surprisingly, both Baldan et al. and 
Ranalletta et al. reported a significant decrease in atherosclerotic lesion size 
even when the mice were challenged with a high fat/high cholesterol diet 
(100,101). Baldan et al. attributed the reduction in lesion size to an increase in 
apoptosis of the Abcg1–/– macrophages, whereas Ranalletta et al. proposed that 
upregulation of Abca1 and an associated increase in apoE secretion contributed 
to the reduction in lesion size (100,101).  Conversely, Out et al. reported a 
moderately significant increase in lesion size in the Ldlr−/− mice receiving bone 
marrow from Abcg1−/− mice (102). Furthermore, a subsequent study showed that 
overexpression of ABCG1 in Ldlr−/− resulted in a moderate increase in lesion size 
(103).  
 To further clarify the role of ABCG1 in atherosclerosis, cholesterol efflux 
and its relationship to ABCA1, Abca1−/−Abcg1−/− mice were created and bone 
marrow from these mice was transplanted into hyperlipidemic Ldlr−/− mice 
(99,104) Similar to the studies described above, conflicting results from these 
experiments were also obtained. Out et al. reported that atherosclerotic lesions in 
these mice were smaller than those mice receiving Abca1−/− donor cells, whereas 
Yvan-Charvet et al. reported increased lesion size in mice receiving double 
knockout donor cells as compared to controls (99,104).   
The characterization of the precise physiological role of ABCG1 is still in 
its infancy. Localization studies, mouse models, and overexpression studies have 
begun to outline a molecular mechanism for ABCG1. Discerning the role that 
ABCG1 plays in the intracellular distribution of sterols will be vital in seeking new 
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target molecules and functional pathways in the prevention and treatment of 
cardiovascular disease.   
Yeast as a model system to study sterol homeostasis  
The maintenance of sterol homeostasis is paramount to all eukaryotes.  
Sterol homeostasis is achieved by striking a precise balance between sterol 
synthesis and its uptake, efflux, and catabolism. Despite the importance of these 
homeostatic events, many aspects of these processes and their regulation 
remain elusive. The model eukaryote Saccharomyces cerevisiae, shares many 
aspects of sterol homeostasis with higher eukaryotes (Table 2). The application 
of classical and molecular genetics (including genomics) to Saccharomyces 
cerevisiae has allowed it to serve as a valuable tool in deciphering the 
mechanisms underlying sterol homeostasis (6).  In particular I utilized this model 
system to further our understanding of sterol esterification and ABC transporter 
mediated movement of sterol across membranes. As such, the fundamentals of 
these particular processes in yeast are highlighted in the following section.  
Ergosterol structure and synthesis 
Ergosterol is the predominant sterol in budding yeast and an essential 
structural component of yeast membranes (105). Although it differs structurally 
(double bonds at C7 and C22 and a methyl group at C29) from cholesterol, 
ergosterol is synthesized, regulated, and metabolized in a similar fashion (Figure 
1) (106,107).  Like in higher eukaryotes, budding yeast can obtain ergosterol 
either via its biosynthesis or its uptake from the environment. Sterol biosynthesis, 
which only occurs in the presence of oxygen, is comprised of over twenty distinct 
reactions that take place primarily in the ER (Figure 2) (105,108). The 
biosynthetic pathway is extensively regulated and responds to both 
environmental (changes in intracellular sterol levels) and transcriptional cues. A 
majority of the transcriptional regulation is imparted by the transcription factors, 
Upc2p and Ecm22p, which activate transcription by binding to common 




Sterol Esterification  
 In Saccharomyces cerevisiae, two ACAT related enzymes, Are1p and 
Are2p, catalyze the esterificiation of sterols (110,111). Like in mammalian cells, 
steryl esters are stored in cytosolic lipid droplets as a means to protect the cell 
from cholesterol toxicity (111). Are1p and are2p are 49% identical and are most 
similar to ACAT1 at the carboxy terminus, exhibiting a 23% identity overall 
(https://portal.biobase-international.com/cgi bin/build_ghpywl/idb/1.0/searchengine/start.cgi). 
 
Are1p and Are2p protein structure  
The ARE1 and ARE2 genes produce a predicted 71 kDa and a 74 kDa 
protein respectively (105). In general, sequence conservation of this gene family 
is most pronounced toward the carboxy terminus. Are1p and Are2p both possess 
the conserved motifs, FYxDWWN and (H/Y)SF, of which the former most likely 
mediates acyl-CoA binding and the latter is required for catalytic activity. Similar 
to human ACAT1, deletion of a region in the N-terminus of Are2p results in a 
truncated isoform with increased enzymatic activity (112). Furthermore, Are2p is 
predicted to have multiple transmembrane domains as well as phosphorylation 
and N-linked glycosylation sites (112). 
 
Are1p and Are2p biological activity and regulation   Are1p and Are2p are homotetrameric enzymes that reside in the ER. 
Deletion of both genes results in a viable cell that is completely void of any steryl 
esters. The yeast double mutant can be complemented by the heterologous 
expression of human ACAT1 or ACAT2 cDNAs indicating both functional and 
structural conservation. ARE1 and ARE2 genes differentially determine the sterol 
ester pools of the cell. The deletion of ARE2 results in a 75% decrease in 
ergosteryl esters, whereas the loss of ARE1 has no detectable impact on the 
production of ergosteryl esters in vivo (112).  These discordant phenotypes can 
be explained by the varying substrate specificity of the esterifying enzymes (113). 
Are1p primarily esterifies intermediates in the sterol biosynthetic pathway, 
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whereas are2p is esterifies the end product ergosterol (113). Based on their 
distinct substrate specificity it is not surprising that these two genes are 
differentially regulated in response to alterations in sterol metabolism. The ARE1 
gene is up-regulated by the accumulation of pathway intermediates, 
anaerobiosis, and heme deficiency (the production of which requires oxygen). 
Conversely, ARE2 expression is repressed both under anaerobic and heme 
deficient conditions (112,113).  
  
Sterol Uptake  
Under aerobic conditions yeast fulfill their sterol requirement solely via its 
biosynthesis and therefore do not take up free sterols from the environment 
(114). The molecular mechanism underlying this aerobic sterol-exclusion has not 
yet been defined, however it is though that properties of the cell wall may prevent 
exogenous sterol uptake (115). Conversely, during anaerobiosis, sterol 
biosynthesis is inhibited and therefore yeast cells are forced to uptake sterol from 
the environment (116). Aerobic sterol uptake and sterol biosynthesis can occur 
concurrently as a result of a mutation that prevents the synthesis of heme, 
overexpression of the transcriptional regulator SUT1, and a gain of function 
mutation in the transcription factor UPC2 (this mutant strain will be referred to as 
upc2-1 from herein) (117-119). UPC2 encodes for a member of a fungal 
regulatory family containing the Zn (II)2Cys6 binuclear cluster DNA binding 
domain. Upc2p promotes sterol uptake by binding to the sterol regulatory 
elements in AUS1 and PDR11 (120). Aus1p and Pdr11p are members of the 
ABC transporter superfamily that mediate the retrograde transport of sterols 
(120). 
 
Aus1p and Pdr11p protein structure 
               AUS1 and PDR11 both encode for proteins that are predicted 160 kDa 
and share a 65% identity.  Aus1p and Pdr11p are members of the ABCG subfamily 
and are 25% and 28% identical to ABCG1, respectively (https://portal.biobase-
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international.com/cgi-bin/build_ghpywl/idb/1.0/searchengine/start.cgi).  They are 
full ABC transporters that are comprised of two nucleotide binding domains and 
two transmembrane domains.  Like all members of the ABCG subfamily, the 
nucleotide binding domain is N-terminal to the transmembrane domains. In 
addition, Aus1p and Pdr11p possess a degenerate Walker A motif in the first 
nucleotide binding domain, a common feature of all yeast members of the ABCG 
subfamily (121).  Specifically, the conserved lysine residue in this motif, which is 
thought to essential for ATP binding is substituted with a cysteine residue. The 
Walker A motif of Aus1p and Pdr11p contains a three amino acid deletion that 
encompasses the critical lysine residue (Figure 2) (121). The biochemical or 
functional significance of a degenerate Walker A motif in this subfamily remains 
unknown (121).  
 
 Aus1p and Pdr11p biological activity and regulation 
 In order to establish the components of non-lipoprotein-mediated sterol 
uptake in budding yeast, a genome wide transcriptional analysis of the upc2-1 
mutant strains was utilized (120).  This transcriptional profiling study identified the 
plasma membrane ABC transporters, Aus1p and Pdr11p, as key mediators of 
sterol influx. Initial functional studies of these transporters revealed that they 
differentially contributed to sterol uptake. An AUS1 deletion under anaerobic 
conditions resulted in a significant decrease in sterol uptake.  In contrast, a 
PDR11 deletion under the same conditions had no discernible effect on sterol 
uptake (120).  However, the combined loss of both ABC transporters during 
anaerobiosis abolished sterol uptake and severely compromised viability. The 
redundancy in these transporters was further demonstrated by the finding that 
either transporter alone can supply sufficient sterol to support anaerobic growth 
(120). 
Based on the observation that sterol uptake is significantly decreased in 
are1Δ are2Δ upc2-1 mutant, Prinz et al. examined whether Aus1p and Pdr11p 
play a role in the subsequent intracellular distribution of exogenous sterols (122).  
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Specifically, they investigated whether these two transporters mediate the non-
vesicular transport of sterols to the ER.  Prinz et al found that an AUS1 or PDR11 
deletion resulted in a significant decrease in sterol esterification (used as marker 
for sterol movement to the ER), respectively (122). Thereby suggesting that 
Aus1p and Pdr11p may mediate the movement of sterols to the ER. Furthermore, 
they observed that exogenous cholesterol is more rapidly esterified than  
endogenous ergosterol.  Prinz et al posit that these different rates in esterification 
reflect the distinct yeast raft affinities of these two sterols.  Based on these data, 
Prinz et al propose that Aus1p and Pdr11p increase the availability of plasma 
membrane sterol for esterification in the ER, which in turn contributes to the net 
uptake of exogenous sterol by cells. In addition, they also suggest that the 
propensity of a sterol to be moved between the plasma membrane and ER is 
largely determined by its raft affinity, suggesting that raft association is a primary 
determinant of sterol accumulation in the PM. However, they do not provide a 
transport mechanism by which sterols transported by Aus1p and Pdr11p are 
shuttled from the plasma membrane to the ER (122). 
 AUS1 and PDR11 are primarily regulated by the transcription factors 
Upc2p and Ecm22p.  In addition, AUS1 and PDR11, like Are2p are regulated by 
oxygen status via the transcription factor Hap1 (120).  The PDR11 promoter 
contains an additional response element, a pleitropic drug resistance element, 
which is bound by the transcription factor Pdr1p. Although, PDR11 expression is 
upregulated in response to Pdr1p binding, the functional relevance of this change 
in expression remains to be elucidated. Perhaps Pdr11p mediates cross-talk 




In mammals, an integral component of cholesterol homeostasis is its efflux 
to the environment (18). Until recently, there was no evidence of sterol efflux in 
yeast and therefore it was thought that sterol homeostasis was maintained by the 
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reciprocal interconversion of free sterols and steryl esters (105). However, recent 
studies by Tiwari et al., identified a novel sterol acetylation/deacetylation cycle, 
which plays a pivotal role in controlling export of sterols from the cell.  This sterol 
export cycle is mediated by two proteins, a sterol acetylase Atf2p and a sterol 
deacetylase, Say1p  (123). 
 
Atf2p and Say1p protein structure 
Say1p is an ER protein that is both sequentially and functionally 
homologous to the human arylacetamide deacetylase, AADAC.  It is an integral 
membrane protein that contains a putative esterase/lipase domain and three 
potential N-linked glycosylation sites.  In addition, Say1p possesses a lipase 
consensus motif GXSXG and a HGGG oxyanion hole motif, which are the 
hallmark sequences of the prokaryotic family IV lipolytic enzymes (which display 
a high similarity to mammalian hormone-sensitive lipases).  Atf2p is an alcohol 
O-acetyltransferase that is found in the ER. It is an integral membrane protein 
with at least two transmembrane domains.  Atf2p has no know mammalian 
homologues however it is 35% identical to Atf1p. Atf2p has a conserved 
heptapeptide WRLICLP, which is proposed to be part of the active site of alcohol 
O-acetyltransferases (56). 
 
Atf2p and Say1p biological activity and regulation 
 Biochemical analysis of a say1Δ strain revealed an accumulation of a 
sterol derivative, steryl acetate (123). Conversely, deletion of ATF2 resulted in 
the absence of intracellular sterol acetate (123).  Since it was already established 
that Atf2p possessed acetylase activity and produces sterol acetate, it was 
surmised that SAY1 encoded for a deacytelase (124). Functional and 
biochemical characterization of a say1Δ strain showed that acetylated cholesterol 
not only accumulated intracellularly, but was also present in the culture 
supernatant. These data suggested that Say1pʼs deacteylation of sterols 
promotes their retention within the cell, whereas, acetylation by Atf2p marks the 
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sterols for export (123). Tiwari et al, showed that similar to sterol efflux in 
mammals, the presence of an exogenous lipid acceptor was necessary for efflux 
to occur (123).  Furthermore, export of steryl acetate is an ATP dependent 
process that requires an intact secretory pathway.  In order to assess if 
cholesteryl ester formation influences the acetylation/deactylation cycle, Tiwari et 
al generated a say1Δ are1Δ are2Δ mutant strain and assessed the presence and 
export of cholesteryl acetate. They found that export of cholesterol acetate 
occurred less efficiently in this background (123).  Although Tiwari et al, 
described the presence of sterol efflux in yeast, they failed to show which 
proteins mediate the efflux of sterols (123). 
Regulation of At2p and Say1p remains elusive.  Tiwari et al, showed that 
oxygen status did not effect expression of either of these proteins. However, data 
presented by Wilcox et al., showed that the Atf2p promoter contains Upc2p 




Purpose of this study 
ABC transporters constitute an extensive evolutionarily conserved 
superfamily of integral membrane proteins have recently been implicated in 
intracellular lipid trafficking (70). The first example of this arose when mutations 
in the ABC transporter ABCA1, were identified as the molecular defect in Tangier 
disease, a disease typified as a defect in HDL cholesterol metabolism (125). 
These proteins exclusively force anterograde movement of cholesterol across the 
plasma membrane. In contrast, we have demonstrated that the opposite (i.e 
inward) transport of sterol in yeast is also dependent on two ABC transporters 
(Aus1p and Pdr11p). The main focus of this study is to define the parameters that 
influence ABC transporter mediated sterol movement across membranes. The 
comparison between these contrasting states (opposing directionality of the 
same substrate) will allow us to dissect whether sterol transport across the 
plasma membrane is defined by the molecule (i.e. the ABC transporter) or by 
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microenvironment (i.e. the status of intracellular proteins and lipids) in which it 
resides. In order to address this question in Chapter 2, I will express murine 
ABCG1 (mABCG1) in budding yeast and assess how changes in the intracellular 
sterol environment affect direction of transport. In the subsequent chapters 
(Chapter 3 and 4) we will explore how interactions with proteins in the 
microenvironment influence sterol transport by members of the ABCG subfamily.  
These studies may deepen our understanding of how members of the ABCG 
subfamily transport sterols and how dysregulation of this transport may contribute 



























Function Lipids transported Disease state/mutant 
phenotype 
ABCA1 Apo-A1 dependent 
formation of nascent HDL 
C, PL Tangiers Disease 
Familial HDL Deficiency 
ABCA2 Unknown, correlated with 
C concentration in brain 
SM, myelin Alzheimerʼs Disease 
(putative) 
ABCA3 Secerete pulmonary 
surfactant 
C, SM, PC Neonatal surfactant 
deficiency, Pediatric 
interstitial lung disease 
ABCA4 (ABCR) Retinal integrity  Ret, PE Age-related macular 
degeneration, Stargardt 
disease 1, Retinitis 
pigmentosa 19,  
ABCA6 Unknown, sterol regulated  ? 
ABCA7 Unknown C, PL ? 
ABCA9 Unknown, sterol regulated  ? 
ABCA10 Unknown, sterol regulated  ? 
ABCA12 Maintains the integrity of 
lamellar granules 
C, Cer, FA Lamellar ichthyosis type 2 
Harlequin ichthyosis 
ABCB1 (MDR1)  PL, SM, & GSL Parkinsons 




PC Progressive Familial 
Intrahepatic Cholestasis 
ABCG1 Promote cholesterol efflux 
to HDL-2 & HDL-3 particles 
C, SM Athereosclerosis  
ABCG4 Promote cholesterol efflux 




Secretion of plant sterols 
and cholesterol into bile 
C, sitosterol Sitosterolemia 
AUS1, PDR11 Influx of sterol during 
anaerobiosis in yeast 
Ergosterol? Anaerobic inviability 
Table 1:  Members of the ATP binding cassette super-family of membrane associated 
transporters involved in lipid movement.  Abbreviations; C, cholesterol; Cer, ceramide; PL, 





Protein Family Yeast Protein Mouse Protein % Identity  











Pdr11 ABCG1 29% Sterol 
Transport 





































Figure 1: Chemical structure of mammalian and plant sterols and their 
derivatives.  Ergosterol is structurally similar to cholesterol. Both are 










Figure 2. A summary of the key steps in cholesterol and ergosterol 
biosynthesis. Cholesterol is synthesized in almost all cell types from acetyl-
CoA. Ergosterol and cholesterol synthesis is a complex process (simplified here), 














Figure 3 Protein topology of Aus1p and Pdr11p.  Aus1p and Pdr11p are full 
ABC transporters that are members of the ABCG subfamily.  Like all members of 
this subfamily, the nucleotide binding domain (NBD) is N-terminal to the 
transmembrane domain.  Both Pdr11p and Aus1p contain a degenerate Walker A 





Figure 4. A comparison of ABC transporter mediated cholesterol transport 
in a macrophage and budding yeast. Cholesterol transport in both model 
systems is mediated by two ABC transporters that translocate a common 
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Chapter 2:  Changes in the Intracellular Sterol Environment Influence 
Transport Activity of Members of the ABCG Subfamily 
Abstract 
ATP-binding cassette (ABC) transporters represent a group of 
evolutionarily conserved transmembrane proteins that have recently been 
implicated in intracellular lipid trafficking. Most significantly, mutations in 
the ABC transporter ABCA1, were found to be the underlying molecular 
defect in Tangier disease, highlighting its role as a key regulator of HDL 
metabolism.  ABCA1 along with ABCG1/G4 (members of the ABCG 
subfamily) are recognized as key components of the reverse cholesterol 
transport pathway. To date, the ABC superfamily in higher eukaryotes has 
been associated with anterograde movement of sterol across the plasma 
membrane.  However, we have demonstrated that the opposite (i.e 
inward) transport of sterol in yeast is also dependent on two members of 
the ABCG subfamily (Aus1p and Pdr11p), raising the question whether 
direction of transport is an inherent property of the transporter or is 
dictated by the lipid and protein microenvironment in which the transporter 
resides. To answer this question we expressed mABCG1 in budding yeast 
and assessed intracellular cholesterol levels in various genetic 
backgrounds. We found that expression of mABCG1 in budding yeast can 
increase or decrease the concentration of exogenous sterols found inside 
the cell in response to an altered intracellular sterol microenvironment.  
Moreover, we found that Aus1p and Pdr11p contribute to the efflux of a 
sterol derivative, steryl acetate.  A deletion of either AUS1 or PDR11 
results both in a significant intracellular accumulation and a decrease in 
the extracellular concentration of cholesteryl acetate. Our findings suggest 
that ABC transporter activity for this subfamily is influenced by the 




The fundamental role of the plasma membrane is to provide a barrier to 
the extracellular environment, while precisely regulating the transit of molecules 
in and out of cell.  ATP-binding cassette (ABC) transporters are essential 
constituents of the membrane transport machinery (1).  These transporters utilize 
energy derived from ATP binding and/or hydrolysis to transport a vast array of 
substrates across membranes, usually against a concentration gradient (1).  This 
protein superfamily represents one of the largest classes of transport proteins 
and is conserved throughout evolution (2).  Human ABC transporters are 
classified into seven families (six of which are found in Saccharomyces 
cerevisiae) (3), based on similarity in protein topology, number of domains, and 
on sequence identity in the nucleotide binding and transmembrane domains. 
Members of the seven families of human ABC transporters mediate various 
biological processes such as cholesterol and lipid transport, multidrug resistance, 
and the ATP-dependent regulation of ion channels.  Mutations in these proteins 
have been associated with a myriad of diseases, including cystic fibrosis, Tangier 
disease, and diabetes (2). 
As many as one third of human ABC transporters facilitate lipid or 
cholesterol movement across membranes (4).  ABC transporters were first 
implicated in intracellular cholesterol trafficking when mutations in ABCA1, were 
identified as the molecular defect in Tangier disease, highlighting its role as a key 
regulator of HDL metabolism (5). Today, ABCA1 along with ABCG1/G4 are 
recognized as key components of the reverse cholesterol transport pathway (6).  
ABCG1 and ABCG4 act in concert with ABCA1 to maximize the removal of 
excess cholesterol from cells by promoting cholesterol efflux onto mature and 
nascent HDL particles, respectively (7).  To date, mammalian ABC transporters 
are exclusively associated with efflux of cholesterol  (4). 
In budding yeast, as in mammalian cells, members of the ABCG subfamily 
facilitate sterol transport from membranes (8).  Aus1p and Pdr11p are full ABC 
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transporters, which are 26% and 27% identical to ABCG1, respectively 
(https://portal.biobase-international.com/cgi bin/build_ghpywl/idb/1.0/searchengine/start.cgi).  In 
contrast to their mammalian counterparts, Aus1p and Pdr11p mediate sterol 
influx from the environment when sterol biosynthesis is compromised such as 
during anaerobiosis (8).  The deletion of either AUS1 or PDR11 results in a 
significant decrease in sterol uptake and esterification.  The loss of both ABC 
transporters during anaerobiosis results in a complete abatement of sterol import 
and a loss of viability, which can be complemented by the expression of either 
transporter (8).  In addition to Aus1p and Pdr11p, the ACAT related sterol 
esterifying enzymes (Are1p and Are2p) and Dan1p, a cell wall mannoprotein, 
also play an instrumental role in mediating sterol influx (8,9). Deletion of these 
genes produces a significant decrease in sterol uptake (8).  However, the precise 
mechanism by which these proteins mediate sterol influx has not been 
elucidated.  
Once imported into the cell via the sterol influx pathway, it was previously 
thought that sterols in budding yeast undergo one of two possible fates.  
Incoming sterols can either be incorporated into membranes or esterified and 
stored in cytosolic lipid droplets (10,11).  Recent data has shown that sterols can 
also be acetylated and effluxed from the cell (12).  Steryl acetate export is 
mediated by a sterol acetylation/deacetylation cycle, in which acetylation by Atf2p 
marks the sterol for export, whereas deactelyation by Say1p targets it for 
retention in the cell. Moreover, steryl acetate efflux requires ATP, the presence of 
an exogenous acceptor molecule, and an intact secretory pathway (12).  
Characterization of the efflux pathway is incomplete, as the mechanisms that 
mediate the actual efflux of steryl acetate have not been identified.  
Cholesterol movement across membranes in budding yeast and 
mammalian cells requires members of the ABCG subfamily (4,8).  In either model 
system, these transporters localize to the plasma membrane where they promote 
the flux of cholesterol across a membrane (8,13).  However, the net transport of 
cholesterol occurs in opposite directions.  The transport of the same sterol 
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substrate in opposite directions in these two model systems, highlights an 
important question about the mechanism by which ABC transporters mediate the 
transport of sterols. In particular what determines directionality of transport? The 
comparison between these contrasting states (opposite transport of the same 
substrate) will allow us to dissect whether sterol transport is an inherent property 
of the transporter or dictated by the microenvironment (defined as the  
surrounding proteins and lipids that the transporter resides in) (Chapter 1, Figure 
4).  We hypothesize that directionality of transfer is either an inherent property of 
the transporter or determined by the microenvironment in which it resides.  
In order to elucidate the mechanisms that dictate direction of transport we 
expressed murine ABCG1 (mABCG1) in budding yeast and assessed cholesterol 
flux. We observed that expression of mABCG1 varied the concentration of 
exogenous radiolabelled cholesterol found within the cell, depending on sterol 
status of the intracellular microenvironment. Furthermore, we found that the 
budding yeast orthologues of ABCG1, Aus1p and Pdr11p, contribute to the efflux 
of cholesteryl acetate as a function of their interactions with the cellular lipid and 
proteo-lipid environment.  These finding suggest that mABCG1, Aus1p, and 
Pdr11p promote bi-directional transport in order to maintain sterol homeostasis.  
This is the first example of eukaryotic ABC transporters being able to mediate 
anterograde and retrograde transport of sterol and a sterol derivative.  The 
manner in which this is achieved will be the focus of this chapter.  
 
Materials and Methods 
 
General.Yeast strains used in this study are isogenic with the strain W303-1A 
(Table 1). These strains were transformed with pRS424-GPD/ABCG1 or 
pRS424-GPD using lithium acetate followed by prototrophic selection.  SAY1 
deletion strains were generated using the one-step PCR mediated gene 
disruption (14). 
Analysis of exogenous sterol accumulation, acetylation, and esterification.  In 
pulse label studies cells were grown to mid-log phase in the appropriate media 
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and inoculated with 1% tyloxapol/ethanol (1:1) and 0.01 μCi/ml [4-14C]cholesterol 
for four hours.  The net accumulation of [4-14C]cholesterol in the cells was 
measured by scintillation counting.  For steady state studies, cells were grown for 
approximately 20 h in the indicated media containing 1% tyloxapol/ethanol (1:1) 
and 0.01 μCi/ml [4-14C] cholesterol.  The net accumulation of [4-14C]cholesterol in 
the cells was measured by scintillation counting.  Assays were performed on 
three independent isolates of each genotype.  Statistical analysis was performed 
using Student's t tests. 
For quantification of cholesteryl acetate, mutant strains were cultured with 
1% tyloxapol/ethanol (1:1) and 0.01 μCi/ml [4-14C]cholesterol for 20 hours.  Cells 
were washed and grown in fresh media containing 40 μg/ml of cold cholesterol 
for 20 hours.  Lipid were extracted from the media and the dried cell pellet by 
organic extraction by established methods and resolved by TLC in petroleum 
ether/diethyl ether/acetic acid (84:15:1).  Lipids were detected using iodine 
staining and quantified via scintillation counting.  Assays were performed on 
three independent isolates of each genotype. Statistical analysis was performed 
using Student's t tests. 
Northern Blotting. RNA was isolated as previously described and resolved on a 
1.2% agarose, formaldehyde gel.  The membrane was hybridized with a random 
oligonucleotide-primed (Stratagene) [32P dCTP-labeled probe, made from PCR-
generated inserts of each gene examined.  The hybridization was carried out in 
QuikHyb buffer (Stratagene) for 1 h at 65 °C.  The membrane was washed twice 
with 2× saline-sodium citrate (SSC) buffer, 0.1% sodium lauryl sulfate (SDS) at 
room temperature and once with 0.1× SSC, 0.1% SDS at 65 °C.  
Growth Curves. Growth curves were obtained using a Microbiology Workstation 
Bioscreen C (Thermo Electron Corp.) and Research Express Bioscreen C 
software (Transgalactic Ltd.).  Cultures (three isolates per genotype) were 
normalized to an A600 of 0.1, and 10 μl of each strain was added to 290 μl of the 
appropriate media per well. 
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Lipid Droplet Isolation and Quantification. The indicated strains were grown in 
500 ml YPD overnight at 30 °C for 20 hours.  Cells were washed and lysed, and 
microsomes were prepared from a 100,000 × g spin, as previously described. 
The lipid rich fraction at top of the centrifuge tube was collected.  Lipids were 
extracted as described above. Protein concentrations were determined utilizing 
the Lowry method. 
 
Results 
Expression of mABCG1 mediates sterol transport in budding yeast. ABCG1 plays 
a pivotal role in promoting cholesterol efflux and is the most similar mammalian 
transporter to Aus1p and Pdr11p (45% and 44% sequence similarity, 
respectively).  All three proteins are members of the ABCG subfamily and 
therefore possess the characteristic topology of having their nucleotide binding 
domain N-terminal to the transmembrane domain (Chapter 1, Figure 3) (15,16). 
To determine if mABCG1 can modulate sterol transport in budding yeast, we 
expressed mABCG1 in strains deleted for key mediators of sterol influx.  These 
null mutants were generated in a upc2-1 background, which consists of a gain of 
function mutation in the transcription factor UPC2 that allows for aerobic sterol 
uptake (17).  Expression of mABCG1 mRNA was confirmed by northern blot 
analysis (Figure 1A & 1B).  Additionally, to ensure that expression of mABCG1 
does not hinder the enhanced transcriptional regulation conferred by upc2-1, we 
assessed the expression of a known Upc2p target, DAN1 in the presence of 
mABCG1.  We found that expression of DAN1 was unaffected by mABCG1 
(Figure 1C). This indicates that transcriptional regulation by Upc2-1p is unaltered 
in strains expressing vector control or mABCG1. 
To ascertain the ability of mABCG1 to compensate for the loss of either 
Aus1p or Pdr11p, we expressed mABCG1 in strains deleted for either 
endogenous ABC transporter (Figure 2A). These strains were grown to mid-log 
and then pulse labeled with [14C] cholesterol.  Due to the limited availability of 
radiolabled ergosterol, [14C] cholesterol is used 
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in budding yeast.  Previous studies have shown that cholesterol is taken up, 
metabolized, and trafficked in a manner similar to ergosterol  (9)(4).  Expression 
of mABCG1 in pdr11Δ and aus1Δ strains resulted in approximately 100% and 
200% increases respectively, in intracellular cholesterol as compared to vector 
control (Figure 2A).  This suggests that mABCG1 is able to mediate the influx of 
cholesterol in the absence of the endogenous sterol-importing ABC transporters 
and is therefore a functional homologue of Aus1p and Pdr11p.  Furthermore, 
expression of mABCG1 in an AUS1 deletion strain produced a significant 
increase in steryl esters, indicating that mABCG1 mediated influx reflects 
metabolism of sterol and not just binding to the cell (Figure 2B). Additionally, it 
also suggests that cholesterol imported by mABCG1 is trafficked and 
metabolized in a similar manner to sterols influxed by Aus1p and Pdr11p. 
Expression of mABCG1 had the most striking effect in an are1Δ are2Δ double 
deletion, where it increased sterol influx five times more than vector control 
(Figure 2A). Expression of mABCG1 had no effect on intracellular cholesterol 
levels in an aus1Δ pdr11Δ strain (Figure 2A). Conversely, the presence of 
mABCG1 in a upc2-1 strain resulted in a decrease in intracellular cholesterol 
levels as compared to vector control (in a upc2-1 strain) (Figure 2A).  This data 
suggests that mABCG1 may be promoting cholesterol efflux in this context.  
In order to further demonstrate the manner in which ABCG1 mediated 
activity responds to the cells needs, we labeled cells expressing mABCG1 to 
steady state with [14C] cholesterol (Figure 3).  We found that expression of 
mABCG1 produces a 75% increase in intracellular cholesterol in a upc2-1 strain, 
whereas it decreases cholesterol levels in an are1Δ are2Δ strain by 50%.  In an 
aus1Δ strain, expression of mABCG1 had no effect on intracellular sterol levels 
as compared to vector control.  These data suggest that mABCG1 is able to 
modulate intracellular cholesterol levels presumably by mediating both influx and 
efflux of cholesterol.  Furthermore, it appears that the cellular microenvironment 




Cholesteryl Acetate efflux is affected by the deletions of Aus1p, Pdr11p, and the 
esterifying enzymes. To assess if yeast members of the ABCG subfamily are 
capable of promoting bi-directional transport, we measured the acetylation of 
[C14] cholesterol in the absence of Aus1p or Pdr11p (Figure 4A & 4B). We found 
that deletion of either AUS1 or PDR11 in a SAY1 mutant strain results in a 
significant intracellular accumulation of cholesteryl acetate and a significant 
decrease in extracellular cholesteryl acetate.  Additionally, there was no 
significant difference in the percent of free cholesterol or cholesteryl ester 
between the double and single mutants.  These data represent the first example 
of a eukaryotic ABC transporter mediating influx and efflux in the same organism.  
In addition to Aus1p and Pdr11p, it has been shown that a deletion of the 
cell wall protein DAN1 and the esterifying enzymes, ARE1 and ARE2 significantly 
decrease sterol uptake (8,9). In order to ascertain if these proteins also play a 
significant role in the export of cholesteryl acetate, we measured the percent of 
[14C] cholesterol that is acetylated in a dan1Δ say1 and an are1Δ are2Δ say1Δ 
strain (Figure 4). We found that efflux of cholesteryl acetate is independent of 
Dan1p. In contrast, the are1Δ are2Δ say1Δ strain exhibited an estimated four-fold 
increase in intracellular cholesteryl acetate levels as compared to say1Δ.  This 
data suggests that excess free cholesterol is acetylated and primed for export, in 
the absence of the esterification reaction.  
 
Ergosteryl acetate accumulation doesnʼt affect viability. To discern if the 
cholesteryl acetate accumulation seen in the aus1Δ say1Δ, pdr11Δ say1Δ, and 
are1Δ are2Δ say1Δ strains is toxic, we performed a viability assay in the 
presence of 160µg/ml of cholesterol (Figure 5). This concentration of cholesterol 
is eight times higher than what is utilized to support anaerobic growth. We found 
that the double and triple deletion strains grew at a similar rate as a say1Δ single 
deletion in the presence of excess exogenous cholesterol.  This therefore 
suggests that this cholesterol derivative is stored in such a manner that it is not 




Ergosteryl acetate is found in lipid droplets. Lipid droplets protect the cell from 
sterol toxicity by providing an inert respository for excess free cholesterol. To 
determine if lipid droplets play a similar role for cholesteryl acetate, we isolated 
lipid droplets and looked for the presence of cholesteryl acetate (Figure 6).  Lipid 
droplets from an aus1Δ say1Δ and say1Δ strain contained cholesteryl acetate. 
This data demonstrates that cholesteryl acetate can be stored in a lipid droplet. 
 
mABCG1 promotes free cholesterol and cholesteryl acetate efflux in a say1Δ.  
The established role of mammalian ABC transporters is to promote sterol efflux, 
as such we wanted to assay if mABCG1 can also efflux cholesteryl acetate 
(Figure 7).  We found that mACBG1 was unable to rescue the cholesteryl acetate 
accumulation observed in an aus1Δ say1Δ and in an are1Δ are2Δ say1Δ strain. 
However when expressed in a say1Δ strain, mABCG1 significantly increased the 
efflux of both cholesteryl acetate and free cholesterol.  
 
Discussion 
Cholesterol homeostasis is essential to the cell and therefore is precisely 
regulated by multiple proteins and pathways working in concert (18).  ABC 
transporter mediated movement of cholesterol is an integral component of 
cholesterol homeostasis; the loss of which in some conditions can result in 
significantly decreased viability in both macrophages and budding yeast  (8,18). 
However, despite the pivotal role that ABC transporters play in preserving 
cholesterol homeostasis, very little is known about the mechanism that facilitates 
transport of sterols by these proteins (4). The data presented here demonstrate 
that alterations in the sterol microenvironment of the cell influence the transport 
properties of these proteins.  We found that expression of mABCG1 in budding 
yeast is capable of altering intracellular cholesterol levels. 
Expression of mABCG1 in a upc2-1 strain produced a significant decrease 
in intracellular sterols as compared to vector control in the same background. 
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This observation may be attributed to the fact that in a upc2-1 strain, sterol 
biosynthesis and sterol uptake occur concurrently (4), therefore mABCG1 
mediated efflux may provide the cell with a rapid and alternate sterol 
detoxification pathway.  Conversely, when mABCG1 was expressed in strains 
with diminished sterol uptake (aus1Δ, pdr11Δ, are1Δ are2Δ) it produced a 
significant increase in sterol influx as compared to vector control.  This increase 
in uptake may reflect the cellʼs metabolic need for sterols.  Moreover, the partial 
rescue of the sterol uptake phenotype of are1Δ are2Δ by the expression of an 
ABC transporter, suggests that the decrease in uptake seen in an are1Δ are2Δ 
strain  (9) may be due to a negative feedback inhibition of Aus1p and Pdr11p.  
Surprisingly, mABCG1 was unable to mediate sterol influx in an aus1Δ pdr11Δ 
strain.  This observation may demonstrate an inability of mABCG1 to interact with 
cell wall proteins that have been shown to mediate sterol influx (8).  Alternatively, 
mABCG1 mediated sterol transport may require that sterol first bind to to Aus1p 
or Pdr11p and as a result requires their expression to mediate sterol influx.   
When we performed a steady state label of the various deletion strains we 
found conflicting results from our pulse label studies.  Expression of mABCG1 in 
upc2-1, are1Δ are2Δ, and aus1Δ strains produces a significant increase, a 
significant decrease, and no change in intracellular sterol levels respectively. 
We hypothesize that the opposing effects exerted by mABCG1 are due to 
the varying intracellular cholesterol kinetics seen in a transient state (pulse label) 
versus a steady state.  The opposing effects exerted by mABCG1 in these two 
contrasting states in the same strain highlights that the metabolic needs and 
environment of the cell modulate cholesterol transport by mABCG1.  The data 
presented here exhibits the first occurrence of a mammalian ABC transporter 
mediating retrograde transport of cholesterol depending on the cellular context. 
Moreover, we have shown that expression of mABCG1 in budding yeast can also 
decrease intracellular levels and promote cholesterol efflux.  Similar to 
mammalian cells, efflux of cholesterol by ABCG1 in budding yeast was 
accompanied by a corresponding decrease in intracellular cholesterol levels.  As 
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such we propose that mABCG1 mediated decrease in intracellular levels reflects 
efflux of sterols.   
 Similarly, we have also shown that Aus1p and Pdr11p may mediate bi-
directional transport.  In addition to their established role of promoting sterol influx 
(8), we have shown that Aus1p and Pdr11p contribute to the efflux of cholesteryl 
acetate. However, surprisingly deletion of either transporter did not abolish 
cholesteryl acetate completely.  This data suggests that either transporter can 
partially compensate for the loss of the other.  The observation that Atf2p, Aus1p 
and Pdr11p function in the same pathway is corroborated by Wilcox et al., who 
reported that these genes are all upregulated by a common transcription factor, 
Upc2p (8).  The production and export of cholesteryl acetate contributes to the 
maintenance of sterol homeostasis (12). Therefore, like mABCG1, Aus1p and 
Pdr11p, can alter direction of transport of direction to preserve sterol 
homeostasis.  Surprisingly, expression of mABCG1 was not able to rescue the 
intracellular cholesteryl acetate accumulation associated with an are1Δ are2Δ 
say1Δ or aus1Δ say1Δ mutants.  In both strains, sterol uptake and esterification 
is significantly decreased (4). As such these strains may be compensating for the 
loss of a sterol resevoir by storing steryl acetate, as seen in an aus1Δ say1Δ 
mutant.  Conversely, when the ability to store sterols is intact such as in a say1Δ 
strain, then the homeostatic reaction is pushed towards efflux.  This data further 
indicates that the sterol microenvironment of the cell, in this case steryl ester 
stores, may influence ABCG1 mediated transport activity. 
We have utilized a model system to explore the factors that influence 
direction of transport by members of the ABCG subfamily.  Our data collectively 
shows that changes in the surrounding sterol environment of the transporter can 
elicit a change in direction of substrate transport.  Moreover, this data suggests 
that direction of transport is not a static property of the transporter but rather can 
adapt in response to environmental cues.  Similarly, expression of mABCG1 in 
baby hamster kidney cells redistributed membrane cholesterol to cholesterol 
oxidase-accessible surface domains, which could then either be effluxed to HDL3 
  
54 
or influxed to the esterifying enzymes (19). As such we posit that cholesterol 
transporting ABC transporters do not possess directionality per se, but utilize 
energy from ATP hydrolysis to redistribute membrane cholesterol in order to 
enhance its rate of projection from the membrane.  Biophyscial studies have 
demonstrated that sterols not in lipid ordered domains are more susceptible to 
cholesterol oxidase and possess enhanced collisional interactions with water-
soluble reactants (20).  However, the observation that ABC transporter mediated 
cholesterol movement does indeed modulate direction in response to the cellular 
environment canʼt be ignored.  We propose that direction of transport is dictated 
by cellular cues, specifically, by the balance of extracellular and intracellular 
protein/lipid acceptors.  Interestingly, in baby hamster kidney cells the proportion 
of free cholesterol imported to the ACATs decreased in the presence of HDL3 
(19). This suggests that the presence of HDL3 tipped the direction of transport 
towards efflux (19).  Identifying the intracellular and extracellular acceptor 
molecules will be paramount in understanding how these ABC transporters 
maintain cholesterol homeostasis. The data presented here highlights the 
constant need of the cell to strike a precise balance between sterol esterification 
and efflux.  In the next two chapters we further expound on the proteins that help 














Table 1. Strains utilized in this study 
Strain Relevant Genotype Reference 
SCY955 MATa upc2-1 hi, ade2-1, can1-1, trp1-1, ura3-1, 
his3-11, 15, leu2-3, 112 
(4) 
SCY1837 MATa upc2-hi, ade2-1, can1-1, trp1-1, ura3-1, 
his3-11, 15, leu2-3, 112, pdr11::URA3, GFP-
AUS1 
(4) 
SCY2916 MATa upc2-1 hi, ade2-1, can1-1, trp1-1, ura3-1, 
his3-11, 15, leu2-3, 112, aus1::URA3, GFP-
PDR11 
(4) 
SCY267 MATa upc2-1 hi, ade2-1, can1-1, trp1-1, ura3-1, 
his3-11, 15, leu2-3, 112, are1::HIS2, are2::URA3 
(4) 
SCY1296 MATa upc2-1 hi, ade2-1, can1-1, trp1-1, ura3-1, 
his3-11, 15, leu2-3, 112, dan1::URA3  
(4) 
SCY2120 MATa upc2-1 hi, ade2-1, can1-1, trp1-1, ura3-1, 
his3-11, 15, leu2-3, 112, aus1::URA3, 
pdr11::LEU2 
(4) 
SCY1837a MATa upc2-hi, ade2-1, can1-1, trp1-1, ura3-1, 
his3-11, 15, leu2-3, 112, pdr11::URA3, GFP-
AUS1, say1::Nat 
This study 
SCY2196a MATa upc2-1 hi, ade2-1, can1-1, trp1-1, ura3-1, 
his3-11, 15, leu2-3, 112, aus1::URA3, GFP-
PDR11, say1::Nat 
This study 
SCY1296a MATa upc2-1 hi, ade2-1, can1-1, trp1-1, ura3-1, 
his3-11, 15, leu2-3, 112, dan1::URA3, say1::Nat 
This study 
SC207a MATa upc2-1 hi, ade2-1, can1-1, trp1-1, ura3-1, 





Table 2. Primers utilized in this study 
Primer Sequence 
5ʼ SAY1 KO ATGGCAGCCAACTCTGGTCTCGACTCAAAAGTTGAATATTAT 
CGGCTTCAAcatggaggcccagaataccc 















Figure 1. Northern blot analysis of mabcg1 and DAN1 expression in strains 
expressing mABCG1. 
A.  The indicated strains were transformed with PRS424-GPD and PRS424-
GPD/mABCG1. RNA was isolated from these strains and subjected to northern blot 
analysis utilizing a [32P]dCTP-labeled probe made from PCR-generated inserts of 
mABCG1. We found mABCG1 expression in various genetic backgrounds. B. Ethidium 
bromide staining exhibits equal loading of RNA. 
C. RNA was isolated from the indicated strains and subjected to northern blot analysis 
utilizing a [32P]dCTP-labeled probe made from PCR-generated inserts of DAN1. DAN1 
expression was unaffected by the presence of a mABCG1. D. RNA was isolated from 
UPC2 and upc2-1 strains and subjected to northern blot analysis utilizing a [32P]dCTP-
















































Figure 2A. Expression of mABCG1 alters intracellular cholesterol 
concentration and distribution. The indicated strains were transformed with 
pRS424-GPD (empty vector or vector control) or pRS424-GPD/mABCG1. Cells were 
grown to mid-log phase and labeled with media containing 0.01 μCi/ml [4-14C]cholesterol 
for four hours. Net accumulation 14C]cholesterol in the cells was measured as described 
under “Experimental Procedures”.  Experiments were performed in triplicate and the data 
above reflects the mean % of ± S.E intracellular [4-14C]cholesterol of  vector control in 
the same background. Asterisks denote statistically significant difference from vector 
control for strains of the same background expressing pRS424-GPD/mABCG1 with 


























































































Figure 2B. Expression of mABCG1 alters intracellular cholesterol 
concentration and distribution  Cells were grown to mid-log phase and labeled with 
media containing 0.01 μCi/ml [4-14C]cholesterol for four hours. Lipids were extracted 
from the dried pellet by organic extraction and resolved by TLC in petroleum 
ether/diethyl ether/acetic acid (84:15:1). Experiments were performed in triplicate and 
the data above reflects the mean % of ± S.E intracellular [4-14C]cholesterol of  vector 
control in the same background. Asterisks denote statistically significant difference from 
vector control for strains of the same background expressing pRS424-GPD/mABCG1 

























































Figure 3. Expression of mABCG1 alters intracellular cholesterol levels in 
cells labeled to steady state with [4-14C]cholesterol. Cells were grown for 
approximately 20 hours in the appropriate media containing 1% tyloxapol/ethanol (1:1) 
and 0.01 μCi/ml [4-14C]cholesterol. Net accumulation of [4-14C]cholesterol in the cells 
was measured as described under “Experimental Procedures” and reflects the mean % 
of cholesteryl ester of the upc2-1 hi strain. Experiments were performed in triplicate and  
and the data above reflects the mean % of ± S.E intracellular [4-14C]cholesterol of  vector 
control in the same background. Asterisks denote statistically significant difference from 
vector control for strains of the same background expressing pRS424-GPD/mABCG1 









Figure 4A. Aus1p, Pdr11p, and the esterifying enzymes affect cholesteryl 
acetate metabolism. A. The indicated strains were cultured with 1% tyloxapol/ethanol 
(1:1) and 0.01 μCi/ml [4-14C]cholesterol for 20 hours. Cells were washed and grown in 
fresh media containing 40 ug/ml of cold cholesterol for 20 hours.  Lipid were extracted, 
resolved, and quantified as described in “Materials and Methods”. Experiments were 
performed in triplicate and the data above reflects the mean % of ± S.E exogenous [4-
14C]cholesterol acetylated intracellularly and in the culture media. Asterisks denote 























Figure 4B. Aus1p, Pdr11p, and the esterifying enzymes affect cholesteryl 
acetate metabolism. A. The indicated strains were cultured with 1% tyloxapol/ethanol 
(1:1) and 0.01 μCi/ml [4-14C]cholesterol for 20 hours. Cells were washed and grown in 
fresh media containing 40 ug/ml of cold cholesterol for 20 hours.  Lipid were extracted, 
resolved, and quantified as described in “Materials and Methods”. Experiments were 
performed in triplicate and the data above reflects the ratio of  % of exogenous [4-
14C]cholesterol acetylated over total % of ± S.E exogenous [4-14C]cholesterol acetylated . 
Asterisks denote statistically significant difference from the control strain with p<0.05 (*) 







































































Figure 4C.  Aus1p, Pdr11p, and the esterifying enzymes affect cholesteryl 
acetate metabolism. C. The indicated strains were cultured with 1% tyloxapol/ethanol 
(1:1) and 0.01 μCi/ml [4-14C]cholesterol for 20 hours. Lipid were extracted, resolved, and 
quantified as described in “Materials and Methods”. Experiments were performed in 
triplicate and the data above reflects the mean % of ± S.E [4-14C]cholesterol esterified. 















Figure 4D. Aus1p, Pdr11p, and the esterifying enzymes affect cholesteryl 
acetate metabolism.  The indicated strains were cultured with 1% tyloxapol/ethanol 
(1:1) and 0.01 μCi/ml [4-14C]cholesterol for 20 hours. Lipid were extracted, resolved, and 
quantified as described in “Materials and Methods”. Experiments were performed in 
triplicate and the data above reflects the mean % of ± S.E free [4-14C]cholesterol. 
Asterisks denote statistically significant difference from the control strain with p<0.01 (**) 













Figure 5. Ergosteryl Acetate accumulation does not affect viability. 
Growth curves were obtained using a Microbiology Workstation Bioscreen C (Thermo 
Electron Corp.) and Research Express Bioscreen C software (Transgalactic Ltd.). 
Cultures (three isolates per genotype) were normalized to an A600 of 0.1, and 10 μl of 































Figure 6A. Ergosteryl Acetate is found in lipid droplets.  A. Dilute inoculation 
of each strain into 500 ml of YPD were grown overnight at 30 °C into log phase Lipid 
droplets were isolated as described in “Materials and Methods”.  Lipids were extracted 
as described in “Materials and Methods”.  Abbreviations: EE-Ergosteryl Ester, EA-



























































Figure 6B. Ergosteryl Acetate is found in lipid droplets. Extracted lipids were 
























Figure 7A. mABCG1 promotes cholesteryl acetate and free cholesterol 
efflux in a say1Δ mutant only. The indicated strains were transformed with pRS424-
GPD (empty vector) or pRS424/mABCG1. These strains were cultured with 1% 
tyloxapol/ethanol (1:1) and 0.01 μCi/ml [4-14C]cholesterol for 20 hours.  Cells were 
washed and grown in fresh media containing 40 ug/ml of cold cholesterol for 20 hours. . 
Lipid were extracted, resolved, and quantified as described in “Materials and Methods”. 
Experiments were performed in triplicate and the data above reflects the mean of  % of ± 
S.E exogenous [4-14C]cholesterol acetylated. Asterisks denote statistically significant 
difference from empty vector in the same strain background with p<0.05 (*) and p<0.01 































































Figure 7B. mABCG1 promotes cholesteryl acetate and free cholesterol 
efflux in a say1Δ mutant only.  The indicated strains were transformed with 
pRS424-GPD (empty vector) or pRS424/mABCG1. These strains were cultured with 1% 
tyloxapol/ethanol (1:1) and 0.01 μCi/ml [4-14C]cholesterol for 20 hours.  Cells were 
washed and grown in fresh media containing 40 ug/ml of cold cholesterol for 20 hours. . 
Lipid were extracted, resolved, and quantified as described in “Materials and Methods”. 
Experiments were performed in triplicate and the data above reflects the mean of  % of ± 
S.E free [4-14C]cholesterol. Asterisks denote statistically significant difference from 
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Chapter 3: Characterizing Protein-Protein Interactions for the Yeast Acyl-
Coenzyme A:sterol Acyltransferase, Are2p by Integrated Split-Ubiquitin 





The esterification of sterols by the acyl-coenzyme A:cholesterol 
acyltransferases (ACATs) represents a critical component of intracellular 
cholesterol homeostasis.  However, the mechanism by which sterol substrates 
are transported to the ACATs remains poorly defined. In order to elucidate this 
transport pathway, we performed a split-ubiquitin membrane yeast two-hybrid, 
utilizing the budding yeast orthologue of the ACATs, ACAT-related enzyme 2 
(Are2p). As a result of our screen we identified nine potential interacting partners 
of Are2p.  Strains deleted for these genes all exhibit sensitivity to exogenous 
cholesterol and five of these display decreased esterification activity. We also 
demonstrated that two of the hits, mfb1Δ and cos8Δ are synthetically lethal with 
are1Δ are2Δ in the presence of tunicamycin and myriocin respectively. 
Additionally, we found that Are2p physically interacts with Pdr11p, a member of 





Eukaryotic membranes are comprised of a precise lipid organization that is 
acclimatized for optimal cellular function (1).  Cholesterol is a cardinal 
determinant of this membrane lipid organization and therefore is subject to 
scrupulous regulation. The cell possesses an armamentarium of mechanisms 
and metabolic pathways that work in concert to achieve cholesterol homeostasis 
(1).  The esterification of cholesterol by the ACATs is a first line defense 
mechanism employed by the cell against increasing cholesterol levels. A 10% 
increase in cell surface cholesterol results in a 3- fold increase in esterification 
activity within an hour (2). Similarly, in budding yeast the ACATs also play an 
essential role in maintaining sterol homeostasis.  The absence of the sterol 
esterifying enzymes produces a decrease in sterol biosynthesis or sterol uptake 
(3). Despite the paramount role the ACATs play in maintaining intracellular 
cholesterol equilibrium, the mechanisms by which sterols are shuttled to the 
ACATs are unknown (4). Abrogation of classical sterol transport mechanisms 
such as membrane vesicle trafficking or the endosomal-lysosomal pathway in 
model systems does not effect esterification of sterols originating from the cell 
surface (3,5). These data suggest that transport of the sterol substrate to the 
ACATs may be facilitated by soluble sterol binding proteins or a previously 
uncharacterized vesicular system.   
To date, little progress has been made towards identifying molecular 
components of this transit despite its major contribution to sterol homeostasis 
within the cell. This may in part be due to the inability of prevailing methodologies 
to identify protein partners for membrane proteins (6).  Yeast two-hybrid systems 
are the most frequently used method to detect protein-protein interactions (7). 
However, intrinsic to this system is itʼs bias towards detecting interactions 
between soluble proteins and their binding partners. Transmembrane proteins 
are significantly underrepresented in these studies due to their hydrophobic 
nature and their inability to successfully translocate to the nucleus, a requirement 
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of yeast two hybrid systems (7).  Recently a modified yeast two hybrid has been 
devised to allow for the identification of integral membrane interacting proteins. In 
the split ubiquitin membrane yeast two hybrid, a membrane protein of interest or 
the "bait," is fused to the C-terminal half of ubiquitin (Cub), along with an artificial 
transcription factor that consists of the bacterial LexA-DNA binding domain and 
the Herpes simplex VP16 transactivator protein (8). This strain is then 
transformed with the “prey”, a yeast DNA library comprised of DNA fragments 
that are fused to the N-terminal half of ubiquitin (Nub). Upon interaction of two 
proteins, the ubiquitin moiety is reconstituted (Cub + Nub) and is subsequently 
recognized by cellular ubiquitin proteases resulting in the cleavage of the 
transcription factor. The released transcription then enters the nucleus and 
activates transcription of the reporter genes (8). 
In order to elucidate the mechanisms of sterol transport from the cell 
surface to the ACATs, we performed an integrated membrane split ubiquitin 
yeast two hybrid utilizing the yeast ACAT related esterifying enzyme, Are2p as 
bait.  As a result we identified nine putative Are2p interacting proteins.  In order to 
explore the role of these interactors in sterol metabolism, we performed a series 
of viability assays in the presence of exogenous cholesterol and drugs that 
perturb sterol homeostasis. As a result we found that MFB1 and COS8 are 
synthetically lethal with are1Δ are2Δ in the presence of tunicamycin and myriocin 
respectively. Analysis of the viability assays demonstrated that the interactors 
assayed, play a previously uncharacterized role in sterol homeostasis. 
Materials and Methods 
General.  Yeast strains used in this study are isogenic with the strain W303-1A 
(Table 1). Deletion strains were generated using the one-step PCR mediated 
gene disruption (9) . We were unable to create a deletion of COS12 in the W303 
background.   
Growth Curves.  Growth curves were obtained using a Microbiology Workstation 
Bioscreen C (Thermo Electron Corp.) and Research Express Bioscreen C 
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software (Transgalactic Ltd.). Cultures (three isolates per genotype) were 
normalized to an A600 of 0.1, and 10 μl of each strain was added to 290 μl of the 
appropriate media per well. 
Analysis of exogenous sterol accumulation and esterification.  Cells were grown 
for approximately 20 h in the indicated media containing 1% tyloxapol/ethanol 
(1:1) and 0.01 μCi/ml [4-14C]cholesterol.  Sterols were extracted and analyzed via 
thin layer chromatography (8). 
Matlab Analysis: Maximum Rate and Time at Maximum Rate quantification- The 
MATLAB program was programmed by Kelly Ruggles in order to find the slope of 
the growth curve at each time point, and then identifying the maximum slope (or 
rate) for each triplicate in each strain.  The time (in hours) at which this slope was 
reached was also stored in a new matrix table.  Values of these variables were 
calculated for each individual growth curve.  Statistical significance was obtained 
by performing an unpaired t-test for each growth parameter.  The values were 
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ODRatio = ODnorm(xxxΔ )ODnorm(WT )
 
 
Pronger assay and anaerobic growth. Aliquots from 2 ml media were plated as 
serial dilutions and grown anaerobically for 3 days on YEPD plates supplemented 
with 20 μg/ml ergosterol and 0.5% Tween 80 as an oleate source. Anaerobic 
growth was achieved using BD PharMingen, CO2-generating gas packs and jars 
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as described previously. Attainment of anaerobiosis was monitored by the 




Characterization of Are2p integrated split-ubiquitin membrane yeast two-
hybrid. In order to execute this screen the C-terminus of Are2p was fused in 
frame with the Cub construct via homologous recombination in the yeast reporter 
strain THY AP4 (8). To assess if the Cub-tagged bait protein was properly 
inserted into the membrane and not self-activating, we transformed these strains 
with control prey plasmids containing an ER protein, Ost1p that is fused to either 
NubI (a hyperactive positive control) or NubG (comprised of a point mutation that 
inhibits interaction). The Are2p-Cub construct was able to interact with the 
positive control Ost1-Nub1 and did not exhibit any growth in the presence of 
Ost1-NubG.  Furthermore, metabolic incorporation studies demonstrated that this 
construct exhibits esterification activity (Figure 1).  These experiments 
demonstrate that Are2p-Cub is expressed, correctly inserted into the membrane, 
and possesses esterfication activity.  The Are2p-Cub containing strain was 
subsequently transformed with a yeast genomic “prey” library. Two hundred 
colonies were scored as positives for activation of the reporter system, which is 
measured by growth on media lacking histidine and adenine or blue colony color 
in the presence of X-gal. Genomic DNA was extracted from these colonies, 
transformed back into the bait strain, and growth on the appropriate media was 
assessed.  Eighty-five of these colonies activated the indicated reporter genes in 
the presence of the Are2p bait. Eighty percent of the plasmid DNA retrieved from 
these colonies represented background noise such as stretches of the 
mitochondrial genome, autonomously replicating sequences, or non-coding 
regions.  Seventeen sequences encoded for open reading frames.  Of these, 
eight proteins were eliminated based on redundancy with other split ubiquitin 
screens or not being in frame. As a result nine proteins remained after all of the 
  
75 
verification assays were completed (Table 2). Of these nine, Cos8p was the only 
hit identified in the screen twice, with two non-overlapping sequences.  Some of 
the interactors identified have previously known interactions either with each 
other or Are2p.  Pdr11p (a member of the ATP binding cassette transporter 
superfamily) and Are2p have both been implicated in playing an integral role in 
the import of sterols (10,11).  Additionally, Cos12p has been reported to 
physically interact with Nup84p and is part of the same protein family (the 
DUP380 family) as Cos8p (https://portal.biobase-international.com/cgi-
bin/build_ghpywl/idb/1.0/searchengine/start.cgi). Moreover, the double deletion of 
GLT1 and MFB1 has been shown to produce a synthetic sick phenotype 
(http://drygin.ccbr.utoronto.ca/).  In order to further elucidate the functional and 
genetic interactions of these proteins, we performed an esterification assay and a 
series of viability tests.  
 
Five Deletion Mutants of Are2p Interactors Exhibit a Significant Decrease in 
Sterol Esterifcation.  The primary role of Are2p is to esterify sterols and as such 
its deletion results in a 75% decrease in sterol esterification  (10). To assess if 
the interactors identified play a role in transport of sterols to Are2p or regulate the 
esterifying enzyme, we created a deletion mutant of each of the nine candidate 
genes in a upc2-1 strain and measured the esterification of exogenous 
radiolabelled cholesterol.  The upc2-1 strain contains a gain of function mutation 
in the transcription factor encoded by UPC2, that facilitates aerobic sterol influx.  
Of the nine mutants, deletion of COS8, SIP18, MFBI and YJR096W and 
particularly PDR11, resulted in significant decreases in the percent of exogenous 
sterol esterified (Figure 2). Pdr11p works in concert with its closest paralog, 
Aus1p, to mediate the influx of sterols during anaerobiosis  (11). Due to their high 
degree of similarity and functional redundancy in sterol uptake (11) we also 
assessed sterol esterification in an aus1 deletion. We found that loss of AUS1 
results in a profound decrease in the percent of sterol esterification (Figure 2). 
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These data implicate that these protein either mediate sterol transport or 
positively regulated Are2p. 
 
All of the interacting proteins are sensitive to excess cholesterol in the media.  
The esterification of free sterols represents a major sterol detoxification pathway 
in yeast (10). To delineate if Are2p interacting proteins mediate sterol 
detoxification, we assessed viability of the deletion mutants (in a upc2-1 
background) in the presence of 150 µg/ml of cholesterol. This concentration of 
cholesterol is seven and a half times greater than what is utilized to support 
anaerobic growth (12).  Viability is defined as a composite of three parameters, 
which include the rate of growth, the time it takes to reach the maximum rate 
optical density (OD), and the OD at the peak of growth. Although all of the hits 
displayed a significant sensitivity to increased exogenous cholesterol, none were 
as striking as a nup84Δ strain (Figure 3).  This data suggests that these 
interacting proteins play a role in maintaining cholesterol homeostasis although to 
varying degrees. 
 
Aus1Δ, Cos8Δ, and Glt1Δ are sick anaerobically when deleted in an are1Δ are2Δ 
strain. To investigate the role of these interactors in sterol uptake under 
physiological conditions, deletion mutants were grown anaerobically. Aus1Δ was 
the only single mutant to show a slight decrease in growth.  However, Cos8Δ 
are1Δ are2Δ, aus1Δ are1Δ are2Δ, and glt1Δ are1Δ are2Δ all grew worse when 
compared to their respective single deletion or an are1Δ are2Δ double mutant 
(Figure 4A & 4B).  This data suggests that these three proteins may mediate 
alternate pathways that help maintain sterol homeostasis in the absence of the 
esterification reaction.  
 Deletion mutants in a upc2-1 background exhibit flucanazole sensitivity. ARE1 
and ARE2 genes differentially determine the sterol ester pools of the cell due to 
their disparate substrate specificity (13). Are1p primarily esterifies intermediates 
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in the sterol biosynthetic pathway, whereas are2p is esterifies the end product 
ergosterol (7).  To assess if the interactors demonstrate similar substrate 
specificity as Are2p, we assessed the viability of the deletion mutants in the 
presence of fluconazole.  Fluconazole is a triazole antifungal drug that inhibits the 
fungal cytochrome P450 enzyme, 14α-demethylase. As a result, fluconazole 
prevents the conversion of lanosterol to ergosterol and therefore produces an 
intracellular accumulation of 4α-methyl-sterols (normally substrates for Are1p) 
(7,10). We found that a deletion of COS8, GLT1, MFB1, NUP84, or PDR11 in a 
upc2-1 background all grew significantly slower than the control strain (Figure 5).  
Interestingly, deletions of MFB1, PDR11, and COS8 displayed a significant 
decrease in the percent of sterol esterified (Figure 3). This data suggests that 
either these proteins may play a dual role in positively regulating both Are1p and 
Are2p or they able to transport various sterol substrates.  
A majority of the Are2p interacting proteins display a myriocin related phenotype.            
The metabolism of sphingolipids and cholesterol are precisely co-regulated (14). 
To investigate whether the identified hits play a role in sphingolipid metabolism 
we measured their viability in the presence of myriocin. Myriocin is an inhibitor of 
serine palmyitoyltransferase, the enzyme that catalyzes the first step in 
sphingosine biosynthesis.   Myriocin treatment results in a depletion of 
intracellular sphingolipids and a concurrent increase in free sterols (presumably 
due to loss of lipid rafts) (3).  In 50 ng/ml of myriocin, only a NUP84 deletion (in a 
wild type background) exhibited a significant decrease in viability, whereas glt1Δ, 
mfb1Δ, pdr11Δ, cos8Δ, and sip18Δ strains all grew significantly better than the 
control strain (Figures 6A, 6B, & 6C).  The most striking myriocin phenotype was 
observed in a cos8Δ are1Δ are2Δ strain, which was synthetic lethal in 60ng/ml of 
myriocin (Figure 6D). This data suggests that these proteins share an essential 
biological function in response to myriocin treatment. In contrast sip18Δ are1Δ 
are2Δ, grew significantly better than an are1Δ are2Δ strain, suggesting that 
Sip18p may be a negative regulator of Are1p and Are2p (Figure 6D). In an upc2-
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1 background, only an AUS1 deletion resulted in significantly diminished growth 
(Figure 6E).     
A majority of the hits display a tunicamycin related phenotype. The unfolded 
protein response (UPR) is an evolutionarily conserved series of reactions that 
mediate the folding, processing, export, and degradation of misfolded proteins. In 
addition to protein misfolding, lipid and structural changes in membranes may 
also induce the UPR (15).  To investigate the relationship of the interactors and 
the UPR, we treated the various deletion strains with tunicamycin, an established 
inducer of the UPR (16). The most compelling phenotype was observed in an 
mfb1 are1Δ are2Δ strain, which exhibited a synthetic lethal phenotype, 
suggesting that these proteins mediate compensatory parallel pathways in 
response to an induction of the UPR (Figure 7A). Conversely, we found that 
cos8Δ are1Δ are2Δ, sip18Δ are1Δ are2Δ, and nup84Δ are1Δ are2Δ strains all 
grew significantly better than an are1Δ are2Δ strain (Figure 7A).  In an upc2-1 
background, cos8Δ, are2Δ, and sip18Δ all displayed a significant decrease in 
viability (Figure 7B).  
Discussion 
The esterification of sterols represents a critical component of sterol 
homeostasis that is conserved throughout eukaryotic evolution (1).  Despite its 
fundamental role in preserving dynamic sterol equilibrium, there is exiguous 
information regarding how sterol substrates are transported to the enzymes (2). 
In order to identify components of this sterol transport pathway we performed a 
membrane split ubiquitin yeast two hybrid utilizing Are2p as our bait.  As a result 
of our screen and subsequent viability assays we discovered nine putative Are2p 
interacting proteins and established a previously uncharacterized role for them in 
mediating sterol homeostasis. Interestingly, we demonstrated that two of the hits, 
mfb1Δ and cos8Δ are synthetically lethal with are1Δ are2Δ in the presence of 
tunicamycin and myriocin respectively. This is particularly striking as true 
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synthetic lethal phenotypes are rare, occurring less than one percent in genome 
wide screens (17). 
 Cos8 is a member of the duplicated (DUP) gene family, one of the largest 
and uncharacterized gene families in budding yeast (18).  Broadly, it is thought 
that this family of proteins may act as facilitators activating or stabilizing 
membrane proteins, as is the suggested role for Cos3pʼs interaction with Nha1p 
(a Na+/H+ antiporter) (18).  Although there is a dearth of information regarding the 
specific function of Cos8p, there is some evidence that suggests Cos8p may 
negatively regulate the synthesis of very long chain fatty acids and consequently 
sphingolipid production (19).  As such we hypothesize that Cos8p may co-
regulate the esterification reaction (postivie regulation) and sphigolipid 
biosynthesis (negative regulation), providing another point of cross-talk between 
these two major metabolic pathways. Further characterization of this interaction 
is necessary to further elucidate the role of Cos8p in sterol esterification and 
metabolism. 
Mfb1p, is a mitochondrial protein that regulates the mitochondrial tubular 
network and is a member of the F-box protein family (15). This protein family acts 
as adaptors for multiple proteins, mediating the formation of macromolecular 
complexes that play key roles in diverse cellular processes (20). The role for 
mitochondria in sterol uptake and metabolism in yeast has been established but 
not characterized in-depth (21). Therefore, a physical interaction between the 
esterifying enzyme and a mitochondrial protein is not that surprising.  However, 
the synthethic lethality between these genes in response to tunicamycin was 
unexpected, as none of these proteins have been previously implicated in 
mediating the UPR. This data suggests that Mfb1p and the esterifying enzymes 
may play an overlapping essential role in inducing the UPR. Interestingly, studies 
from mammalian cells and Caenorhabditis elegans have shown the existence of 
a mitochondrial UPR response that activates transcription of nuclear-encoded 
mitochondrial chaperone genes to promote protein homeostasis within the 
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organelle (22). Based on these findings we propose that the loss of intracellular 
sterol stores during budding (period of increased membrane proliferation) may 
have a two-fold effect: one it may inhibit mitochondrial tubular proliferation (which 
may induce the mitochondrial UPR) and two induce the UPR due to defects in 
membrane proliferation.  As a result of this hyperinduction of the UPR, this strain 
is inviable. However, further characterization of this interaction and the role of this 
complex in the induction of UPR is necessary. 
Our intent when we performed this screen was to find a putative soluble 
protein that mediates the transport of sterols from the cell surface to the ACATs. 
Interestingly, we found that Pdr11p, an ABC transporter that mediates sterol 
uptake may physically interacts with Are2p.  Therefore this data suggests that  
the plasma membrane ABC transporter participates in a protein complex that 
directly transfers sterols to the ACAT enzymes, negating the need for an 
intermediary sterol transport protein.  In the following chapter we will further 
expound on this hypothesis by confirming the physical interaction and exploring 
























Figure 1. The are2-Cub construct is able to esterify sterols comparable to 
wild type. The indicated strains were grown for 18 h to mid-log phase in YEPD media 
containing 1% tyloxapol/ethanol (1:1), fatty acids (Tween 80), unlabeled cholesterol (20 
μg/ml), and 0.01 μCi/ml [4-14C]cholesterol. Anaerobic growth was achieved using BD 
PharMingen, CO2-generating gas packs and jars. Lipids were extracted, resolved, and 
quantified as described in “Materials and Methods”. Experiments were performed in 
triplicate and the data above reflects the mean % of ± S.E [4-14C]cholesterol esterified. 













Figure 2. Decreased esterification activity is associated with a majority of 
the interactors. The indicated genes were deleted in a upc2-1 strain. These strains 
were cultured with 1% tyloxapol/ethanol (1:1) and 0.01 μCi/ml [4-14C]cholesterol for 20 
hours. All other strains were grown for 18 h to mid-log phase in YEPD media containing 
1% tyloxapol/ethanol (1:1), fatty acids (Tween 80), unlabeled cholesterol (20 μg/ml), and 
0.01 μCi/ml [4-14C]cholesterol. Anaerobic growth was achieved using BD PharMingen, 
CO2-generating gas packs and jars (Wilcox paper). The cell pellets were washed twice 
with 0.5% tergitol and once with dH2O, and lyophilized. Lipids were extracted, detected 
and quantified as described in “Materials and Methods”. Experiments were performed in 
triplicate and the data above reflects the mean % ± S.E of [4-14C]cholesterol esterified. 
Asterisks denote statistically significant difference from the control strain with p<0.05 (*) 
and p<0.01 (**) by unpaired t-test. 
 






















































































Figure 3. nup84Δ displays significant sensitivity to exogenous cholesterol.  
The indicated strains were grown in 150 μg/ml of cholesterol in 1:1 tyloxapol:ethanol for 
72 hours. ODs were assessed as described in “Materials and Methods”. Experiments 
were performed in triplicate. Asterisks denote statistically significant difference from the 
control strain (upc2-1) for the time it takes to reach the maximum rate OD with p<0.01 





























































































































































































































































































































Figure 4. Anaerobic viability of deletion mutants.  Cos8Δ, aus1Δ, and glt1Δ are 
synthetic sick with are1Δ are2Δ under anaerobic conditions.  Serial dilutions of the 
indicated strains were done on plates containing cholesterol (20 μg/ml) and Tween 80. 
Anaerobic growth was achieved using BD PharMingen, CO2-generating gas packs. B. 
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Figure 5. A significant number of Upc2-1 deletion mutants exhibit 
sensitivity to flucanazole. The indicated strains were grown in the presence of 20 
μg/ml of flucanazole. ODs were obtained as described in “Materials and Methods. 
Experiments were performed in triplicate. Asterisks denote statistically significant 
difference from the control strain (upc2-1) for the time it takes to reach the maximum rate 
OD (nup84Δ) and OD at the peak of growth (mfb1Δ, cos8Δ, glt1Δ, pdr11Δ.) Statistical 




































































































































































































































































Figure 6A. A majority of the hits display a myriocin related phenotype. The 
indicated strains were grown in 50 ng/ml of myriocin for 72 hours. Experiments were 
performed in triplicate. Asterisks denote statistically significant difference from the control 
strain for the time it takes to reach the maximum rate OD (nup84Δ). Statistical 






















































































































































































































































































































































Figure 6 B&C. A majority of the hits display a myriocin related phenotype. 
The indicated strains were grown in 50 ng/ml of myriocin for 72 hours. Experiments were 
performed in triplicate. Asterisks denote statistically significant difference from the control 
strain for the time it takes to reach the maximum rate OD (pdr11Δ, mbb1Δ, glt1Δ), OD at 
the peak of growth (cos8Δ), and rate of growth (sip18Δ). Statistical significance with 










































































































































































































































































































































































































































































































































































































































































Figure 6 D&E. A majority of the hits display a myriocin related phenotype. 
significance with p<0.05 (*) with p<0.01 (**) was assessed by upaired t-test. The 
indicated strains were grown in 60 ng/ml of myriocin for 72 hours ODs were obtained as 
described in “Materials and Methods”. Experiments were performed in triplicate. 
Asterisks denote statistically significant difference from the control strain for OD at the 
peak of growth and rate of growth.  Statistical significance with p<0.05 (*) with p<0.01 





































































































































































































































































































































































































































































































































































































































Figure 7A. Tunicamycin Sensitivity of the Interactors.  The indicated strains 
were grown in 0.6 μg/ml of Tunicamycin for 72 hours. ODs were obtained as described 
in “Materials and Methods”. Experiments were performed in triplicate. Asterisks denote 
statistically significant difference from the control strain for the OD at the peak of growth 
(glt1Δ are1Δ are2Δ and mfb1Δ are1Δ  are2Δ) and for the time it takes to reach the 
maximum rate OD (nup84Δ are1Δ are2Δ and cos8Δ are1Δ are2Δ). Statistical 
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Figure 7B. Tunicamycin Sensitivity of the Interactors.  The indicated strains 
were grown in 0.6 μg/ml of Tunicamycin for 72 hours. ODs were obtained as described 
in “Materials and Methods”. Experiments were performed in triplicate. Asterisks denote 
statistically significant difference from the control strain (upc2-1) for the time it takes to 
reach the maximum rate OD (nup84Δ are1Δ are2Δ and cos8Δ are1Δ are2Δ). Statistical 





Table 1: Strains utilized in this study. 
Strain Relevant Genotype 
SCY955 MATa upc2-1 hi, ade2-1, can1-1, trp1-1, 
ura3-1, his3-11, 15, leu2-3, 112 
SCY955a MATa upc2-1 hi, ade2-1, can1-1, trp1-1, 
ura3-1, his3-11, 15, leu2-3, 112, aus1::NAT 
SCY955b MATa upc2-1 hi, ade2-1, can1-1, trp1-1, 
ura3-1, his3-11, 15, leu2-3, 112, pdr11::NAT 
SCY955c MATa upc2-1 hi, ade2-1, can1-1, trp1-1, 
ura3-1, his3-11, 15, leu2-3, 112, cos8::NAT 
SCY955d MATa upc2-1 hi, ade2-1, can1-1, trp1-1, 
ura3-1, his3-11, 15, leu2-3, 112, glt1::NAT 
SCY955e MATa upc2-1 hi, ade2-1, can1-1, trp1-1, 
ura3-1, his3-11, 15, leu2-3, 112, mfb1::NAT 
SCY955f MATa upc2-1 hi, ade2-1, can1-1, trp1-1, 
ura3-1, his3-11, 15, leu2-3, 112, nup84::NAT 
SCY955g MATa upc2-1 hi, ade2-1, can1-1, trp1-1, 
ura3-1, his3-11, 15, leu2-3, 112, sip18::NAT 
SCY955h MATa upc2-1 hi, ade2-1, can1-1, trp1-1, 
ura3-1, his3-11, 15, leu2-3, 112, 
yjr096w::NAT 
SCY955i MATa upc2-1 hi, ade2-1, can1-1, trp1-1, 
ura3-1, his3-11, 15, leu2-3, 112, are2::URA 
SCY325 MATa, ade2-1, can1-1, trp1-1, ura3-1, his3-
11, 15, leu2-3, 112 
SCY325a MATa, ade2-1, can1-1, trp1-1, ura3-1, his3-
11, 15, leu2-3, 112, aus1::NAT 
SCY325b MATa, ade2-1, can1-1, trp1-1, ura3-1, his3-
11, 15, leu2-3, 112, pdr11::NAT 
SCY325e MATa, ade2-1, can1-1, trp1-1, ura3-1, his3-
11, 15, leu2-3, 112, cos8::NAT 
SCY325f MATa, ade2-1, can1-1, trp1-1, ura3-1, his3-
11, 15, leu2-3, 112, glt1::NAT 
SCY325g MATa, ade2-1, can1-1, trp1-1, ura3-1, his3-
11, 15, leu2-3, 112, mfb1::NAT 
SCY325h MATa, ade2-1, can1-1, trp1-1, ura3-1, his3-
11, 15, leu2-3, 112, nup84::NAT 
SCY325i MATa, ade2-1, can1-1, trp1-1, ura3-1, his3-
11, 15, leu2-3, 112, sip18::NAT 
SCY325j MATa, ade2-1, can1-1, trp1-1, ura3-1, his3-
11, 15, leu2-3, 112, yjr096w::NAT 
SCY1090 MATa, ade2-1, can1-1, trp1-1, ura3-1, his3-




Strain Relevant Genotype 
SCY1090b 
 
MATa, ade2-1, can1-1, trp1-1, ura3-1, his3-11, 
15, leu2-3, 112, are1::HIS, are2::LEU, 
aus1::NAT 
SCY1090c MATa, ade2-1, can1-1, trp1-1, ura3-1, his3-11, 
15, leu2-3, 112, are1::HIS, are2::LEU, 
pdr11::NAT 
SCY1090d MATa, ade2-1, can1-1, trp1-1, ura3-1, his3-11, 
15, leu2-3, 112, are1::HIS, are2::LEU, 
cos8::NAT 
SCY1090e MATa, ade2-1, can1-1, trp1-1, ura3-1, his3-11, 
15, leu2-3, 112, are1::HIS, are2::LEU, 
glt1::NAT 
SCY1090f MATa, ade2-1, can1-1, trp1-1, ura3-1, his3-11, 
15, leu2-3, 112, are1::HIS, are2::LEU, 
mfb1::NAT 
SCY1090g MATa, ade2-1, can1-1, trp1-1, ura3-1, his3-11, 
15, leu2-3, 112, are1::HIS, are2::LEU, 
nup84::NAT 
SCY1090h MATa, ade2-1, can1-1, trp1-1, ura3-1, his3-11, 
15, leu2-3, 112, are1::HIS, are2::LEU, 
sip18::NAT 
SCY1090i MATa, ade2-1, can1-1, trp1-1, ura3-1, his3-11, 




















Table 2. Characterization of Hits 
 
 
Table 2. Characterization of hits.  Abbreviations: NE-nuclear envelope, MOM-mitochondrial 













Cos8p DUP380 ER, NE Unknown NA NA NA 










DPYD 22% Mfb1 
(negative 
genetic) 




NA NA Glt1 
(negative 
genetic) 












ABCG1 27% NA 
Sip18p NA Cytoplasm Phospholipid 
Binding 
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 Chapter 4: Physical Interactions between AcylCoA-Sterol-Acyltransferases 
and ATP binding cassette transporters. 
Abstract 
Acyl-coenzyme A:cholesterol acyltransferases (ACATs) play a pivotal role in 
intracellular lipid and membrane homeostasis by catalyzing the esterification of 
free sterols with fatty acids.   Surprisingly, the mechanism by which the 
substrates are delivered to the ACATs remains poorly defined.  We performed a 
membrane-associated yeast two hybrid screen utilizing the budding yeast 
ortholog of the ACATs, ACAT-related enzyme 2 (Are2p) to identify protein 
interactions that mediate lipid transfer.  We discovered that in addition to 
undergoing self-multimerization, Are2p physically interacts with Aus1p and 
Pdr11p, members of the G sub-family of ATP binding cassette (ABC) membrane 
transporters.  Are2p, Aus1p, and Pdr11p were found to co-localize to the 
endoplasmic reticulum and the plasma membrane in cold detergent resistant 
membrane microdomains (DRMs) and to co-immunoprecipitate after covalent 
crosslinking.  Deletion of either ABC transporter resulted in Are2p re-localization 
from DRMs to a detergent soluble fraction as well as a significant decrease in the 
percent of sterol esterified.  This phenomenon is evolutionarily conserved in the 
murine lung where Abcg1p and Acat1p were observed to co-localize with flotillin-
1, a marker of DRMs.  We propose that co-localization and complex formation of 
sterol esterification enzymes and ABC transporters in DRMs reflects a novel 




 Cholesteryl esters play an integral role in a myriad of metabolic processes 
including lipoprotein assembly in the liver and intestine, intestinal cholesterol 
absorption, as well as cholesterol and fatty acid storage in cytoplasmic lipid 
droplets. The latter event provides a reservoir that safely sequesters these toxic 
substrates until they are required for membrane assembly.  The catalysis of 
sterol esterification is performed by the Acyl-coenzyme A:cholesterol 
acyltransferases (ACATs) and is conserved throughout eukaryotic evolution.  In 
mammalian cells, the ACAT gene family is tripartite, comprising ACAT1, ACAT2 
and DGAT1 (the latter enzyme esterifies diacylglycerols not sterols).  In 
Saccharomyces cerevisiae, sterol esterification is mediated by two ACAT related 
enzymes, Are1p and Are2p.  The deletion of ARE2 encoding the major isoform 
results in a 75% decrease in ergosteryl or cholesteryl esters, whereas deletion of 
both sterol esterifying genes results in a viable yeast cell without steryl esters but 
control levels of trigycerides.  The yeast double mutant can be complemented by 
the heterologous expression of human ACAT1 or ACAT2 cDNAs indicating both 
functional and structural conservation of these pathways from yeast to 
metazoans.  The ACAT reaction is regulated primarily at the posttranslational 
level by allosteric activation of the enzyme by sterols (1).  This can be 
demonstrated both in vitro and in vivo, the latter observation indicating that the 
transport of these membrane components to the esterification enzymes is a 
significant regulatory component of this metabolic pathway. 
The ACAT protein has been long regarded as integral to the ER 
membrane (2,3) with as many as seven transmembrane domains in the case of 
ACAT1 (4).  The functional size of native ACAT in rat liver microsomes ranged 
from 170 to 224 kDa based on radiation inactivation experiments (5,6) while the 
predicted size of the monomeric ACAT1 protein is ~64.8 kDa.  Moreover, cross-
linking studies indicated that ACAT1 purified from rat adrenal gland microsomes 
exists as oligomeric complexes in vitro.  Human ACAT1 most likely interacts with 
itself and this was confirmed by biochemical studies performed in intact cells and 
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in vitro (7).  The ACAT catalytic complex may be solely composed of ACAT1 or 
other proteins including ACAT2.  
Despite playing a pertinent role in both cholesterol metabolism and in the 
development of atherosclerosis, the mechanism by which the cholesterol 
substrate reaches the ACATs remains elusive.  Approximately 50% of the 
cholesterol substrate for ACAT1 originates from a cholesterol oxidase accessible, 
endogenous cellular pool (8).  The esterification of this endogenous pool of sterol 
is unaffected by energy depletion, inhibition of membrane vesicle trafficking, and 
defects in the endosomal-lysosomal pathway (9).  These data suggest that 
transport of the sterol substrate to the ACATs may be facilitated by soluble sterol 
binding proteins or a previously uncharacterized vesicular system.  To date, little 
progress has been made towards identifying molecular components of this transit 
despite its major contribution to sterol fluxes within the cell. 
In order to determine if protein-protein interactions mediate sterol transport 
to sites of esterification from the plasma membrane, we performed a split- 
ubiquitin, membrane yeast two-hybrid screen utilizing the major yeast ACAT 
enzyme, Are2p, as bait.  As a result of our screen we identified nine putative 
Are2p interacting proteins (Chapter 3, Figure 3).  Surprisingly, among these 
proteins was the ABC transporter, Pdr11p, which along with Aus1p mediates 
sterol influx during anaerobiosis.  These findings suggest that plasma membrane 
ABC transporters participate in a protein complex that directly transfers sterols to 
the ACAT enzymes and thus regulates the esterification pathway. 
EXPERIMENTAL PROCEDURES 
General.  Yeast strains used in this study are isogenic with the strain W303-1A 
(MATa ade2-1, can1-1, trp1-1, ura3-1, his3-11, 15, leu2-3, 112.  The upc2-1 high 
and low alleles were monitored by quantitative sterol uptake and by PCR of the 
UPC2 and HAP1 loci(10).  Deletion mutant strains were generated and confirmed 
by established methods (Chapter 3, Table 1).  Yeast transformation was 
  
98 
performed with lithium acetate followed by selection on YPD and 100ug/L of 
nourseothricin.  HA tagged constructs of Are1p and Are2p were made as 
previously described (11) 
Analysis of exogenous sterol accumulation and esterification.  Cells were grown 
for approximately 20 h in the indicated media containing 1% tyloxapol/ethanol 
(1:1) and 0.01 μCi/ml [4-14C]cholesterol.  Sterols were extracted and analyzed via 
thin layer chromatography (12) . 
Isolation of lipid rafts from murine lung.  Approximately 300 mg of mouse lung 
was homogenized in 1 ml of lysis buffer (1% Triton X-100, 25mM HEPES, pH 
6.5, 150 mM NaCl, 1 mm EDTA, 1mM PMSF, and protease cocktail (Roche 
Molecular Biochemicals, Indianapolis, IN, USA)) and held at 4°C for 30 minutes.  
The extract was mixed with 1 ml of 2.5M sucrose and overlaid with 6 ml of 30% 
sucrose,  25 mM Hepes 150 mM NaCl) and 4 ml of 5% sucrose and centrifuged 
for 18h at 4°C at 39,000 rpm.  The gradient was separated into 12 fractions, 
collected from the top.   
Isolation of lipid rafts from budding yeast.  10–20 OD600 units of yeast were 
grown at 30°C to log phase and lysed in 750 μl of TNE buffer (50 mM Tris⋅HCl, 
pH 7.4, 150 mM NaCl, 5 mM EDTA 1 mM PMSF and 2.5 μg/ml chymostatin, 
leupeptin, antipain, and pepstatin) by glass bead disruption at 4°C.  Cleared 
lysates (400 µl), were pre-incubated with Triton X-100  (1% final) for 30 min on 
ice and mixed with 2 volumes of 60% Optiprep and overlaid with 2.7 ml of 30% 
Optiprep in TNE.  Samples were centrifuged at 45,000 rpm for 2 h.  Nine 
fractions of equal volume were collected from the top.  
Subcellular fractionation.  Membrane preparations from cells grown for 18 h were 
subjected to discontinuous gradient ultracentrifugation (12). 
Cross linking and immunoprecipitation.  Yeast microsomes (13,14) were 
resuspended in phosphate buffered saline (PBS)/1 mM 
phenylmethylsulphonylfluoride and incubated on ice for 0.5 h. followed by cross-
linking with Dithiobis Succinimidyl Propionate (DSP).    (2 mM final concentration) 
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for 0.5 h at room temperature.  The reaction was quenched with 50 mM of Tris–
HCl pH 7.4 at room temperature for 15 min and solubilized in 10 mM Hepes (pH 
7.5), 150 mM NaCl, 1% Triton X-100, and protease inhibitors.  YFP tagged 
proteins were immunoprecipitated with anti-GFP conjugated agarose beads at 
4°C, washed three times and incubated at 59 °C for 15 m. in SDS sample buffer 
containing 50 mM DTT.  Immunoprecipitation of the HA-epitope tagged enzyme 
(12CA5, Boehringer-Mannheim) from microsomes were performed in the 
presence of the RIPA buffer (9.1 mM Na2HPO4, 1.7 mM NaH2PO4, 150 mM 
NaCl, 1% Triton X-100, 0.5% deoxycholate, 0.1% SDS).  Immunoprecipitates 
were collected on protein G agarose beads (Gibco BRL).  Immunocomplexes 
were washed in the RIPA buffer, resuspended in SDS-sample buffer containing 
b-mercaptoethanol, and resolved by 6.5% SDS-PAGE and immunoblotting with 
chicken anti-Are2p (15) or rabbit anti-HA (Santa Cruz Biotech) antibodies.  
Interaction Screens.  Two versions of yeast two hybrid screens were used for 
these studies.  The “interaction-trap” version and the membrane split ubiquitin 
was executed as previously described (11) (Chapter 3).  
 
β-Galactosidase assays. Quantitative β-galactosidase activity assays of cell 
lysates were performed as previously described (11). 
RESULTS 
Sterol esterification in yeast acts independently of endosomal- vacuolar protein 
sorting. The transport of sterols to the ER from the periphery of the cell is integral 
to cellular sterol homeostasis. This is achieved by a myriad of mechanisms, both 
spontaneous and protein mediated, vesicular and non-vesicular.  Sterol 
esterification at the ER  accomplishes a key change in both physico-chemical 
and biological properties of this lipid (polar to non-polar, membrane participating 
to storage form) that essentially terminates the transport reaction and removes 
the sterol from a regulatory pool.  In yeast, sterol transport and subsequent 
esterification is unaffected by the inhibition of vesicular trafficking and 
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independent of the coat forming protein complexes COPI and COPII (16).  In 
metazoans, the endocytic pathway is a key component of sterol transport from 
the plasma membrane to intracellular organelles. In S. cerevisiae, a number of 
genes have been identified in screens for mutants defective in the internalization 
of pheromone receptor or the fluid-phase endocytic marker, lucifer yellow (17).  
One of these mutants, end3, a member of the evolutionarily conserved EH 
(Eps15 homology) domain family in yeast, exhibits a clear defect in 
internalization, temperature-sensitive growth, and defects in organization of the 
actin cytoskeleton (17).  In order to assess the role of the endocytic pathway in 
transporting sterol to the esterifying enzyme, we measured the percent of 
radiolabeled exogenous cholesterol that is esterified in an END3 null mutant.  We 
found that abrogation of this pathway had no significant impact on sterol 
esterification (Figure 1).  Similarly we assessed the VPS (vacuolar protein 
sorting) pathway that mediates protein transport from the late Golgi to the 
lysosome-like vacuole and thus its integrity.  The analogous 
endosomal/lysosomal pathway of multicellular organisms recycles cholesterol 
between the plasma membrane and lysosomes and ultimately the ER.  In yeast, 
more than 50 vps mutants, disrupt transport to the vacuole. These mutants have 
been categorized based on their morphology as well as their vacuolar protein 
sorting and acidification defects.  In order to ascertain the contribution of this 
pathway in transporting sterols to the ACATs, we measured the percent of sterol 
esterified in 3 distinct vps mutants (vps18, 21, and 28).  We found that disrupting 
the activity of the vacuole in this fashion did not decrease sterol esterification. 
These data suggest that sterol delivery to the site of esterification is independent 
of the retrograde vesicular transport system and the endocytic pathway leading 
us to pursue the role of lipid transporters and protein-protein interactions in this 
process. 
Multimerization of sterol esterification enzymes.  Numerous precedents suggest 
that the sterol esterification reaction is performed by a multimeric complex (5-7).   
To investigate the self-association of these enzymes, we utilized a variant of the 
  
101 
yeast two-hybrid (Y2H) system that primarily detects the interaction of soluble 
domains of partner proteins (18,19).  The full-length open reading frames of 
ARE1 and ARE2 were fused to the operator binding domain of LexA (pLexA-
ARE1, pLexA-ARE2) or to a transcription activation domain (pAD-ARE1, pAD-
ARE2).  Expression and esterification activity of the LexA or AD fusion proteins 
were confirmed by immunoblotting and metabolic incorporation studies.  These 
constructs were co-transformed with a LacZ reporter plasmid and assessed by 
quantitative liquid β-galactosidase assays.  The yeast ACATs homomultimerize in 
this context (Table 1); β-galactosidase activity was significantly elevated when 
pLexA-ARE2 was cotransformed with pAD-ARE2.  Similarly, the Are1p fusion 
proteins encoded by pAD-ARE1 and pLexA-ARE1 formed an active complex and 
activated transcription of the reporter gene (Table 1).  Interestingly, despite 
extensive sequence conservation between these enzyme isoforms (20), we saw 
no evidence for heteromeric interactions; the combination of pLexA-ARE1 and 
pAD-ARE2 or  pAD-ARE1 and pLexA-ARE2 did not significantly activate reporter 
expression (Table 1).    
The physical associations between the ACAT isoforms were further 
assessed and confirmed by co-immunoprecipitation experiments with epitope 
tagged active forms of the Are proteins.  An are1Δ are2Δ strain was co-
transformed with control or HA-ARE expression plasmids.  Microsomes from 
these strains were immunoprecipitated with anti-HA antibody and the eluted 
proteins were blotted using the chicken anti-Are2p antibody or the anti-HA 
antibody (Figure 2).  We observed that Are2p but not Are1p could be co-
immunoprecipitated with HA-Are2p corroborating the two hybrid interactions, 
 
Are2p interacting proteins.  The aforementioned Y2H interaction assay was used 
to screen a yeast genomic library, but to no avail (11).  Several putative 
interacting proteins were identified (HKR1, ECM27, YOR223w, FET3 and BUD4), 
however the deletion of any of these genes had no detectable impact on several 
parameters of sterol homeostasis, including sterol esterification.  To identify more 
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meaningful ACAT binding proteins, we performed an integrated split- ubiquitin 
membrane yeast two hybrid screen utilizing Are2p as bait.  This particular Y2H 
system permits the in vivo detection of membrane associated protein-protein 
interactions (21).  Since the sterol esterification reaction and the ACAT molecules 
are membrane associated, we reasoned that this form of the two-hybrid system, 
had greater potential to reveal meaningful trans-acting interactions.  To 
accomplish this screen, the C-terminus of Are2p was fused in frame with a Cub-
YFP-TF moiety via homologous recombination in the yeast reporter strain THY 
AP4.  The activity of this construct was also confirmed by metabolic incorporation 
studies (Chapter 3, Figure 1).  We then transformed this strain with a yeast 
genomic “prey” library.  As a result of our screen we found nine putative in-frame, 
interacting proteins (Table 2). Of these interactors, Cos12p has been reported to 
physically interact with Nup84p and is part of the same protein family (the 
DUP380 family) as Cos8p. To assess the individual role of each protein in sterol 
esterification, we created a deletion mutant of each of the nine candidate genes 
in a upc2-1 strain and measured the esterification of radiolabelled cholesterol.  
The upc2-1 strain contains a gain of function mutation in the transcription factor 
encoded by UPC2, that facilitates aerobic sterol influx (22).  Of the nine mutants, 
deletion of COS8, SIP18, MFBI and YJR096W and particularly PDR11, resulted 
in significant decreases in exogenous sterol esterification (Chapter 3, Figure 2).  
Pdr11p and its closest paralog, Aus1p, mediate the influx of sterols during 
anaerobiosis (10).  Corroborating our previous work we found that an aus1 
deletion also results in a profound decrease in sterol esterification, even after 
compensation for the reduction in sterol uptake associated with this mutant 
(Chapter 3, Figure 2).  We propose that Pdr11p (and likely Aus1p) act with Are2p 
to modulate the sterol esterification pathway. 
 
Aus1p and Pdr11p localize to plasma membrane and microsomal fractions.  
Aus1p and Pdr11p are full ABC transporters that mediate the retrograde 
transport of sterols, which is the first step in the sterol esterification pathway.  In 
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order to assess the localization of these proteins we tagged both AUS1 and 
PDR11 with YFP in the chromosome by homologous recombination in a upc2-1 
strain, so that their expression could by monitored aerobically by fluorescence 
microscopy.  Aus1p and Pdr11p localized to the periphery of the cell in a 
punctate pattern, consistent with a plasma membrane and/or a cortical ER 
localization (Figure 3A).  The plasma membrane localization was further 
confirmed by a subcellular fractionation (Figure 3B).  To assess the possible co-
localization of these proteins we performed a simple cellular sub-fractionation 
and found that both ABC-transporters localize to microsomes, along with Are2p 
(Fig. 4). This co-localization provides a cellular context for the in vivo interaction 
of these three proteins. 
 
Aus1p, Pdr11p, and Are2p physically interact.  In order to confirm the physical 
interaction of Are2p with Aus1p and Pdr11p, we performed co-
immunoprecipitation assays (Figure 5).  Microsomal fractions were isolated from 
cells, which contained either an Aus1 or Pdr11 YFP fusion and were transformed 
with an ARE2-HA plasmid or vector control.  Proteins were immunoprecipitated 
with anti-GFP conjugated agarose beads in the presence of an exogenous cross-
linker (DSP).   Eluted proteins were blotted using an anti-HA antibody. These 
assays confirm that both Aus1p and Pdr11p physically interact with Are2p. This 
suggests that sterols may be directly transferred from the ABC transporters to the 
ACATs, thereby negating the need for an intermediary sterol binding protein.  
 
Aus1p, Pdr11p, and Are2p co-localize to membrane microdomains.   Cold 
Detergent Resistant Microdomains (DRMs) are cholesterol and sphingolipid rich 
membrane foci common to all eukaryotic organisms.  DRMs serve as membrane 
hubs that integrate various pathways, such as lipid influx and efflux, protein 
trafficking, and signal transduction (23).  To assess whether DRMs play a role in 
the sterol esterification pathway, total membrane proteins were solubilized with 
ice-cold 1% Triton X-100 detergent and fractionated by an Opti-prep gradient 
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centrifugation.  The isolated DRMs were probed with anti-HA and anti-GFP 
antibodies to look for expression of Aus1p, Pdr11p, and Are2p (Figure 6A & 7B).   
In control cells, all three proteins co-localize with the DRM marker Pma1p (Figure 
6).  This suggests that DRMs may provide a platform, that integrates the sterol 
influx and esterification pathways in yeast.  Interestingly, a deletion of either ABC 
transporter significantly altered Are2p localization from a DRM to a detergent 
soluble fraction (Figure 6B). This data suggests that Are2pʼs physical interaction 
with the ABC transporters is necessary for its DRM localization.  We speculate 
that this shift in localization may contribute to the decrease in the percent of 
esterification associated with a deletion of AUS1 or PDR11 (Figure 1).  Based on 
these data we propose that sterol transfer in the cholesterol esterification 
pathway occurs as a consequence of a physical interaction of Aus1p, Pdr11p, 
and Are2p in a DRM fraction. 
 
mABCG1 and mACAT1 co-localize with the DRM marker mFlotillin-1 in murine 
lung.  Aus1p and Pdr11p are members of the ABC-G subfamily and share 
approximately 29% sequence identity with mammalian ABCG1.  The cholesterol 
esterification pathway in higher eukaryotes, as in yeast, is unaffected by defects 
in vesicular trafficking and the endosomal/lysosomal pathway.  Furthermore, 
overexpression of ABCG1 in baby hamster kidney cells significantly increased 
cholesterol esterification (24).   ABCG1 may thereby play a role in the transport of 
cholesterol to the ACATs.  In order to investigate whether ABCG1 and ACAT1 
co-localize, we isolated DRMs from murine lung and probed these fractions with 
ABCG1 and ACAT1 antibodies (Figure 7A).  We found that both proteins co-
localize to DRMs.  Furthermore, we observed that in an ABCG1 KO murine lung 
(Figure 7B), there was more ACAT1 in the detergent soluble fraction than in the 
control mouse. This data suggests that similar to budding yeast, ACAT1ʼs 






The esterification of free cholesterol by the ACATs is an evolutionarily 
conserved component of cholesterol homeostasis that accomplishes a significant 
change in both physico-chemical and biological properties of this lipid.  Prior to 
esterification, the cholesterol substrate requires solubilization by proteins and /or 
membranes, in order to be efficiently delivered to the ACAT reaction and yet the 
manner in which this is achieved, remains elusive.  50% of the ACAT substrate 
pool originates from the plasma membrane and its esterification is unaffected by 
energy depletion, inhibition of membrane vesicle trafficking, and defects in the 
endosomal-lysosomal pathway.  The studies presented here offer an attractive 
mechanism for plasma membrane to ER cholesterol transport.  Our studies in 
yeast show that sterol is transferred from the plasma membrane via the ABC 
transporters, Aus1p and Pdr11p to the ARE2-encoded esterification reaction at 
the ER.  Furthermore, Are2p, Aus1p, and Pdr11p co-localize to both the plasma 
membrane and the ER, particularly in DRMs.  Deletion of either ABC transporter 
results in Are2p re-localization from a DRM to a detergent soluble fraction as well 
as a significant decrease in the percent of cholesterol esterified.  Interestingly, 
this co- localization is conserved; ABCG1 and ACAT1 co-localize with the DRM 
marker flot-1 in murine lung.  Overexpression of human ABCG1 in baby hamster 
kidney cells redistributes membrane cholesterol to cell-surface domains 
(accessible to treatment with the enzyme cholesterol oxidase) and increases 
cholesterol esterification suggesting a physiological role of the interaction 
between these proteins in mammals (24).   
ACAT multimerization is likely required for enzymatic activity and in 
addition the allosteric regulation of activity by sterols.  Interestingly, both Are2p 
and Acat1 contain putative leucine zipper motifs, which mediate protein-protein 
interaction.  Although the exact role of these motifs has not been elucidated, it is 
reasonable that these sites may enhance ACAT homomultimerization.  However, 
leucine zipper motifs have also been shown to promote heterodimerization of 
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proteins.  Therefore, the possibility that these motifs may also promote the 
interaction of the ACATs with other proteins, can not be excluded. 
 Plasma membrane pools of cholesterol are tightly regulated. Modest 
alterations in plasma membrane cholesterol induce a rapid and multifaceted 
homeostatic response.  The esterification of cholesterol by the ACATs is the first 
line defense employed by the cell against increasing cholesterol levels. ACAT 
activity can increase three fold within an hour as a response to just a 10% 
increase in cell surface cholesterol. Intrinsic to this acute response by the ACATs 
is the requirement for rapid cholesterol transport from the plasma membrane to 
the ER (25).  We and others have shown that classical cholesterol transport 
mechanisms such as vesicular trafficking or movement of cholesterol through the 
endocytic pathway do not significantly contribute to the transport of cholesterol to 
the ER. Based on our studies we propose that the interaction between members 
of the ABC transporter family and the ACATs promotes rapid cholesterol 
transport from the plasma membrane to the ER. Furthermore, the co-localization 
of these proteins to cholesterol rich DRMs provides an attractive cellular context 
for this transport mechanism to occur. Further characterization of this interaction 
will provide valuable insight as to how these proteins contribute to sterol 
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pAD fusion   pLexA fusion two-hybrid interaction  
(Miller units) 
Are1               Are1 830.1 ± 58.7 
Are1               Max 22.8 ± 4.7 
Mxi                 Are1 21.3 ± 2.0 
Are2               Are2 309.1 ± 15.9 
Are2               Max 40.8 ± 5.5 
Mxi                 Are2 15.2 ± 2.3 
Are1               Are2 52.9 ± 7.1 
Are2               Are1 16.8 ± 3.8 
Mxi                 Max   203.5 ± 12.9 
None              None 16.2 ± 2.8 
  
 
Table 1. Multimerization of sterol esterification enzymes.  The yeast strain 
was transformed with the reporter plasmid pSH 18-34, pAD fusions and pLexA 
fusions as indicated.  β-galactosidase activity was determined in log phase 
cultures in SC-Ura-Trp-His galactose-containing medium as described under 
“Materials and Methods.”  The values (± standard deviation) are the mean of 
three determinations. Two viral proteins, Max and Mxi form a complex 
???However, if pLexA-ARE2 was co-transformed with the vector pAD or with 
pAD-Mxi, b-galactosidase activity was low.  This was also true for pAD-ARE2 
when co-transformed with pLexA or with pLexA-Max.  The combination of pLexA-








Figure 1. Sterol esterification is independent of the endosomal and vacuolar 














Figure 2.  Are2p complexes with HA-Are2p but not with HA-Are1p by co-
immunoprecipitation.  Microsomal proteins were prepared from an are1Δ are2Δ 
strains carrying one or two plasmids as indicated on top of the figure. The strains were 
solubilized and co-immunoprecipitated with anti-HA antibody. The eluate was 
immunoblotted with either anti-Are2p antibody or anti-HA antibody. The arrow indicates 



































Figure 3.  Aus1p and Pdr11p localize to the plasma membrane. A, Fluorescence 
microscopy of Aus1-5ʼYFP and Pdr11-5ʼYFP shows a punctate localization to the 
plasma membrane. B, A western blot of membrane proteins seperated by Renografin 
























Figure 4. Are2p, Aus1p, and Pdr11p localize to the microsomal fraction of the ER. 
The indicated strains were transformed with pRS424 or pRS424/Are2-HA and 
microsomes were isolated. The microsomal fractions were subjected to Western blots. 









































Figure 5. Multimerization of ABC transporters and sterol esterification enzyme. A, 
Co-immunoprecipitation of Aus1-YFP and Are2-HA. Aus1-YFP was transformed with a 
vector control (pRS424) or pRS424/Are2-HA.  Microsomes from these strains were 
solubilized and co-immunoprecipiated with GFP conjugated agarose beads. The eluate 
was immunoblotted with anti-HA.  B, Co-immunoprecipitation of Pdr11-YFP and Are2-
HA. Pdr11-YFP was transformed with a vector control (pRS424) or pRS424/Are2-HA.  
Microsomes from these strains were solubilized and co-immunoprecipiated with GFP 

























































Figure 6A.  ABC-transporters localize to plasma membrane microdomains.  Total 
membrane protein from the indicated strains were solubilized with ice-cold 1% Triton X-
100 and fractionated by an Opti-prep gradient centrifugation. Isolated fractions were run 











































Figure 6B. ABC-transporters localize to plasma membrane microdomains.  Total 
membrane protein from the indicated strains were solubilized with ice-cold 1% Triton X-
100 and fractionated by an Opti-prep gradient centrifugation. Isolated fractions were run 
on gradient SDS-PAGE gel and the Western blot membrane was probed with anti-PMA1 
and anti-HA. Pma1p localization in mutants is the same as that shown in the wildtype 
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Figure 7A.  ABC-transporters and Sterol esterification enzymes localize to 
detergent insoluble domains in mammalian cells.  Expression of Flotillin-1, Acat1, 



































Figure 7B. ABC-transporters and Sterol esterification enzymes localize to 
detergent insoluble domains in mammalian cells.  Expression of Flotillin-1, Acat1, 
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Chapter 5: Conclusions and Future Studies 
 
Conclusions 
ABC transporters comprise one of the largest paralogous protein families 
(1). In humans, ABC transporters are involved in a vast array of cellular 
processes such as nutrient uptake, cell division, and resistance to xenobiotics 
(2). Mutations in ABC transporters cause or contribute to many different 
Mendelian and complex disorders including Tangier disease, cystic fibrosis, 
retinal degeneration, and hypercholesterolemia (3).  Regardless of their distance 
in the evolutionary spectrum and diverse substrate specificity, all ABC 
transporters share one basic biological function-to harness the energy of ATP 
binding and hydrolysis to transport a diverse set of hydrophobic molecules 
across membranes (1). However, direction of substrate transport varies within 
this superfamily. An ABC transporter may function either as a influx or efflux 
pump, but no transporter has been identified to function physiologically in both 
directions (3). Despite their preponderance throughout evolution and their 
significance to human health the mechanisms that regulate direction of transport 
and its activity remain elusive (2). 
In this thesis I have attempted to define the parameters that influence 
direction of transport for sterol transporting members of the ABCG subfamily.   
Members of this subfamily (ABCG1 and ABCG4) are recognized as key 
components in the mammalian reverse cholesterol transport pathway (4). To 
date, mammalian ABC transporters are exclusively associated with efflux of 
cholesterol (3). Contrastingly, in Saccharomyces cerevisiae, we have 
demonstrated that the opposite (i.e inward) transport of sterol in yeast is also 
dependent on two members of the ABCG subfamily (Aus1p and Pdr11p) (5).  As 
such, I exploit these contrasting states (outward v. inward transport of the same 
substrate) to dissect whether substrate transport from the plasma membrane is 
defined by the molecule (i.e. the ABC transporter) or by the microenvironment 
(i.e. the status of other proteins and lipids) in which it resides. 
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To begin to answer this question, in Chapter 2 we expressed mABCG1 in 
budding yeast and assessed transporter activity in varying intracellular sterol 
environments. We found that in strains with diminished sterol uptake (aus1Δ, 
pdr11Δ, and are1Δ are2Δ) expression of mABCG1 was able to promote sterol 
influx (Chapter, Figure 2). Conversely, in an environment of sterol excess (upc2-
1) mABCG1 was able to decrease intracellular levels (Chapter 2, Figure 3) and 
promote sterol efflux (Chapter 2, Figure 4B). Moreover, we found that in addition 
to their established role as influx pumps, Aus1p and Pdr11p contribute to the 
efflux of a sterol derivative, steryl acetate.  A deletion of either AUS1 or PDR11 
results both in a significant intracellular accumulation and a decrease in the 
extracellular concentration of cholesteryl acetate (Chapter 2, Figure 4A & B).  
Our data collectively shows that changes in the surrounding sterol 
environment of the transporter can elicit a change in direction of substrate 
transport.  Moreover, this data suggests that direction of transport is not a static 
property of the transporter but rather can adapt in response to environmental 
cues.  Similarly, expression of mABCG1 in baby hamster kidney cells 
redistributed membrane cholesterol to cholesterol oxidase-accessible surface 
domains, which could then either be effluxed to HDL3 or influxed to the esterifying 
enzymes (6). As such we posit that cholesterol transporting ABC transporters do 
not possess directionality per se, but utilize energy from ATP hydrolysis to 
redistribute membrane cholesterol in order to enhance its rate of projection from 
the membrane. However, the observation that ABC transporter mediated 
cholesterol movement does indeed modulate direction in response to the cellular 
environment canʼt be ignored.  We propose that direction of transport is dictated 
by cellular cues, specifically, by the balance of extracellular and intracellular 
protein/lipid acceptors.  Interestingly, in baby hamster kidney cells the proportion 
of free cholesterol imported to the ACATs decreased in the presence of HDL3 (6). 
This suggests that the presence of HDL3 tipped the direction of transport towards 
efflux.  Identifying the intracellular and extracellular acceptor molecules will be 
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paramount in understanding how these ABC transporters maintain cholesterol 
homeostasis.  
In Saccharomyces cerevisiae and in baby hamster kidney cells, sterols 
transported by members of the ABCG subfamily serve as a substrate for ACAT1 
(6,7). Moreover, studies presented in Chapter 2 demonstrated that the absence 
of the esterifying enzymes affects transport activity of both mABCG1 and its 
budding yeast orthologs. Therefore, we propose that ACAT1 may act as a 
putative intracellular acceptor molecule for these ABC transporters.  In order to 
further expound on this hypothesis, in Chapter 3 we performed a membrane split 
ubiquitin yeast two hybrid to identify protein interactors of Are2p.  As a result of 
our screen and subsequent viability assays we discovered nine putative Are2p 
interacting proteins (Chapter 3, Table 2) and established a previously 
uncharacterized role for them in mediating sterol homeostasis. Interestingly, 
amongst these hits we identified Pdr11p, as a putative interactor of Are2p 
(Chapter 3, Table 2). This suggested that the plasma membrane ABC transporter 
participates in a protein complex that directly transfers sterols to the ACAT 
enzymes.   
 In chapter 4, we performed a series of assays to confirm the physical 
interaction of Are2p and Pdr11p, as well as explore its physiological implications.   
By crosslinking and co-immunoprecipitation assays, we confirmed that that both 
Aus1p and Pdr1p physically interact with the esterifying enzyme, Are2p (Chapter 
4, Figure 6). We also demonstrated that Are2p, Aus1p, and Pdr11p co-localized 
to the endoplasmic reticulum (Chapter 4, Figure 5) and the plasma membrane 
(Chapter 4, Figure 4) in cold detergent resistant membrane microdomains 
(DRMs) (Chapter 4, Figure 7A). This therefore suggests that DRMs may provide 
a platform that integrates the sterol influx and esterification pathways in yeast.  
Interestingly, a deletion of either ABC transporter significantly altered Are2p 
localization from a DRM to a detergent soluble fraction (Chapter 4, Figure 7B), 
suggesting that Are2pʼs physical interaction with the ABC transporters is 
necessary for its DRM localization.  We speculate that this shift in localization 
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may contribute to the decrease in the percent of esterification associated with a 
deletion of AUS1 or PDR11 (Chapter 3, Figure 3).  Based on these data we 
propose that sterol transfer in the cholesterol esterification pathway occurs as a 
consequence of a physical interaction of Aus1p, Pdr11p, and Are2p in a DRM 
fraction. 
The studies presented in this thesis attempt to elucidate the role of 
ABCG1 and its budding yeast orthologs in maintaining sterol homeostasis.  
Collectively, these studies demonstrate that direction of ABC mediated transport 
is not a inherent property of the transporter, but rather it is modulated by the 
presence of lipid and protein acceptors. The data provided here offers further 
insight as to how ABC transporters move cholesterol from the membrane and 
therefore may provide a platform for innovative strategies to combat 
atherosclerosis.   
Future Studies 
 In Chapter 2, we demonstrated that direction of ABC mediated transport is 
not an inherent property of the transporter but rather dictated by cues in the 
microenvironment.  Studies in baby hamster kidney cells showed that sterols 
transported by ABCG1 can be shuttled intracellularly to the ACATs or 
extracellularly to HDL3(6).  Furthermore, the presence of the extracellular acceptor 
promoted efflux of sterols and diminished sterol transfer to the ACATs(6).  To 
firmly establish if direction of transport is dictated by the presence of acceptor 
molecules, I propose to express mABCG1 in budding yeast and supply various 
exogenous acceptors (HDL3 or BSA) in increasing doses and measure 
esterification of sterols.  If acceptor molecules dictate direction I hypothesize that 
as we increase the concentration of exogenous acceptors we should see a 
concurrent decrease in sterol esterification.  By being able to define how ABC 
transporter mediated cholesterol flux is modulated, we may be able provide 
insight as to how to prevent and treat such diseases as atherosclerosis. 
 Another key finding of this chapter was that Aus1p and Pdr11p contribute 
to the export of cholesteryl acetate.  However, the mechanism by which sterols 
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reach the acetylating enzyme, Atf2p at the ER remains elusive. Cholesterol 
acetylation and its subsequent export represents an alternate cholesterol 
detoxification pathway (8).  In order to assess if Aus1p and Pdr11p also directly 
transfer sterol to this detoxification pathway, I propose a cross-linking and co-
immunoprecipitation assay.  If we are able to demonstrate a physical interaction 
between these proteins, I would then assess if this interaction occurs in DRMs.  
This finding would further demonstrate the DRMs play a key role in sterol 
transport and its homeostasis. 
 In chapter 3, we identified nine putative Are2p interacting proteins.  
Interestingly, two of these genes, COS8 and MFB1 produced synthetic lethal 
phenotypes with are1Δ are2Δ in myriocin and tunicamycin respectively.  As a 
result, these proteins in particular warrant follow up experiments to confirm their 
physical interaction and investigate the physiological implications of these 
interactions.  Therefore, initially I would propose performing a co-
immunoprecipitation assay with both of these interactors.  
 In chapter 4, we confirmed that Aus1p and Pdr11p physically interact in 
with Are2p in DRMs and that loss of this interaction has a significant impact on 
sterol homeostasis. Furthermore, we were able to demonstrate that this 
phenomenon is evolutionarily conserved, by showing that mABCG1 and 
mACAT1 also co-localizat to DRMs in murine lung.  However, in order to prove 
that mABCG1 and mACAT1 form a complex in an analogous fashion to their 
budding yeast orthologs, a co-immunoprecipiation assay will be done. It would 
also be interesting to assess if ACAT interaction is specific to ABCG1 or extends 
to other sterol transporting ABC transporters, such as ABCA1 or ABCG5/G8.  
Studies such as these will further our understanding of the mechanisms 
underlying sterol homeostasis and the pathophysiologies that occur as a result of 
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